Improving air quality in metropolitan Mexico City : an economic valuation by Cesar, Herman et al.
POLICY  RESEARCH  WORKING  PAPER  2785
Im proving Air Q  uality in  The annual health  -.erefir  .of
a  i 0 percent rct,  Ai-rl:  :nc  in Metropolitan Mexico  City  ozone and  PM 10  in  Mexico
City,  conservatively estimated,
An Economic  Valuation  are approximately S760
million (in  1999 U.S.  dollars)
annually. Reducing PM 1  0  has
The Mexico Air Quality Management Team *  larger estimated  health
benefits than reducing ozone,
irh each  microgram per
cubic centimeter reduction in
PM I  O worth about $100
million per year.
The World Bank
Latin America and the  Caribbean Region

















































































































dI  POLICY  RESEARCH  WORKING  PAPER  2785
Summary findings
Mexico  City has  for years experienced high levels of  functions from the peer-reviewed literature.  They value
ozone and particulate  air pollution. In  1995-99 the  cases of morbidity and premature  mortality avoided
entire population  of the Mexico  City metropolitan  area  using three approaches:
was  exposed to annual average  concentrations of fine  * Cost of illness and  forgone earnings  only (low
particulate  pollution  (particulates with a diameter of less  estimate).
than  10 micrometers, or PM10)  exceeding  50  *  Cost of illness, forgone  earnings,  and willingness to
micrograms per cubic meter, the annual average standard  pay for  avoided morbidity  (central case estimate).
in both Mexico  and the United States. Two million  * Cost of illness, forgone  earnings,  willingness to pay
people  were exposed to annual average  PM10 levels of  for avoided  morbidity,  and willingness to pay for
more than 75  micrograms per  cubic meter.  The daily  avoided mortality  (high estimate).
maximum one-hour ozone standard was exceeded  at  The results suggest that the benefits  of a  10 percent
least 300 days a year.  reduction in ozone and PM10 in 2010 are  about  $760
The  Mexico Air Quality Management  Team  million (in 1999 U.S.  dollars) annually in the central
documents population-weighted  exposures  to ozone and  case.  The benefits of a 20 percent reduction  in ozone and
PM10  betwccn  1995  and  1999,  project exposures  in  PM10  are  about $1.49 billion annually.  In each case the
2010, and  computes the value of four  scenarios for  benefits  of reducing ozone amount to about  15 percent
2010:  of the total  benefits.
* A  10 percent reduction  in PM10 and ozone.  By  estimatilng the  magnitude  of the beniefits  from air
* A 20 percent reduction  in PM1O  and ozone.  pollution control, the  authors provide  motivation for
* Achievement of ambient  air quality  standards across  examining specific policies  that could achieve  the air
the  metropolitan area.  pollution reductions  that they value. They also provide
* A 68  percent reduction  in ozone and  a 47 percent  unit values for the benefits from reductions in ambient
reduction in PM10 across the metropolitan  area.  air pollution (for example,  per  microgram  of PM10) that
The  authors calculate  the health benefits  of reducing  could be used as  inputs into a full cost-benefit  aiialysis of
ozone and PM10 for each scenario using dose-response  air  pollution  control strategies.
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The Mexico City Metropolitan  Area (Zona Metropolitana  del Valle de Mexico (ZMVM))  has
witnessed  high  levels of air pollution  in  the past  few decades.  Recent  efforts  to  curb  emis-
sions have been reasonably successful,  and  1999  had the  lowest overall level of air pollution
during  the  last  decade.  With  the  exception  of lead,  carbon  monoxide  and  sulfur  dioxide
(S02),  however,  pollution  levels  are  still  far above  current  air quality standards  (See Table
E.1).
Table  E.1: Number  of Days Per Year that Ozone  and PM 10 Concentrations  in Mexico  City
Satisfy Daily Air Quality Standards
1995  1996  1997  1998  1999
Ozone  41  39  43  45  65
PM 10 273  186  212  176  345
Source: GDF  (2000).
Further  efforts to reduce  polluting emissions  are being developed  by the  Comision Am-
biental  Metropolitana  (CAM)  under  the  Third Air Quality  Program  2001-2010.  This  study
presents  an  economic  valuation  of benefits  from  reducing pollution  in  the  ZMVM,  as  the
main economic  rationale  for controlling  emissions  is the welfare gain  from improvements  in
air quality.  The current study focuses on the two most important economic impacts of air pol-
lution,  namely health impacts and restrictions  imposed on  economic  activities  through  envi-
ronmental  contingencies (contingencias ambientales).
The  health  hazards  associated  with  ozone  and  PM1O  are  studied  because  these  sub-
stances  are  the  most  important  in  terms  of violating  pollution  standards.  Ozone  pollution
stems  mainly  from  emissions of NO,  and VOCs.  Their  concentration  levels  depend  on the
amount and location of emitted pollutants,  geographical  characteristics,  meteorological  con-
ditions, and atmospheric  chemistry and transport.  The chemistry of ozone  formation  is com-
plicated  and nonlinear:  under certain  conditions,  an increase  in NO,  emissions  could reduce
ozone concentrations.  PM10 pollution stems  mainly  from direct  emissions  of particles,  and
from reactions  of NO,,  and S02  with  other substances  in  the atmosphere.  Likely  emission
sources  are  building  and  construction  (road  construction),  diesel  trucks  and  buses,  forest
fires, open-air refuse burning, some manufacturing industries,  and resuspension  of road dust.
The daily  1-hour maximum  air quality standard  for ozone  is  0.110 ppm.  During  1995-
99,  the highest  concentration  observed  for  ozone-0.349  ppm-was measured  at the  Pede-
gral  station,  in  the southwest  zone of the  ZMVM.  The  Chapingo  station  in the northeastern
zone  was the  least polluted,  with a daily  1-hour maximum  concentration  of 0.210  ppm.  The
daily average  air quality standard for PMIO  is  150  ,ug/m3  and the annual  average standard  is
50  igIm3.  All stations violated both standards  with the exception  of the annual  average stan-
dard at the Pedregal and Coacalco stations. The highest concentrations  were  in the east of the
ZMVM with a daily maximum of 335  jig/m3  at the Netzahualcoyotl  station.  The highest an-
nual  average  of 94 ug/m3  was  observed  at the  Xalostoc  station.  In  1995,  over  1.2  millionpeople were  exposed to concentrations  above the environmental  contingency  Stage I level of
300 ,g/m3  at least once during the year.
The  baseline  scenario  for  2010  assumes  emissions  of NO,  and  VOCs,  precursors  of
ozone and PM1o, to be the same as at the end of the  1990s.  Likewise,  we assume air quality
in 2010 with respect to ozone and PM1O  to be the same as the levels observed at the end of the
1990s.  This  assumption,  however  crude,  seemed  to be the most appropriate  one in the  ab-
sence of an integrated model of emission projections for 2010 for fixed and mobile sources in
Mexico City.
Four alternative air pollution reduction  scenarios  for 2010 are  evaluated.  We do not ap-
praise  the policies  needed  to achieve  the  concentration  reductions.  The  four scenarios  are
(population weighted exposure reductions are presented in table E.2):
*  a 10-percent reduction  in PM1O and ozone;
*  a 20-percent reduction  in PM10 and ozone;
*  improved air quality compliance  at an air quality standard of 50  Ftg/m3  for PM1O  and
0.11 ppm 1  -hour maximum for ozone in all ZMVM locations (AQS 1);
*  an  air quality  standard  superimposing  the  required  decrease  in  concentrations  in the
most polluted  areas  (Xalostoc  for PM10  and Pedregal  for ozone)  across  the ZMVM
(68  and  47  percent  reduction  in  ozone  and  PMIO  concentrations,  respectively)
(AQS2).
Table E.2:  Reduction in Population-Weighted  Exposure for the Analyzed  Scenarios
Population weighted  Population weighted
exposure to PM 10 Exposure to ozone
Scenario  (ug/m 3/person)  (ppm/person)
10 percent exposure reduction  6.41  0.0114
20 percent exposure  reduction  12.81  0.0227
AQS  compliance in  each  area  - AQSI  14.06  0.0702
AQS compliance in worst area - AQS2  29.99  0.0778
The health risks due to air pollution (specifically ozone and PM1O)  are quantified by es-
timating the relationship  between  the incidence  of adverse health  effects  and air quality.  To
this end,  a number of quantitative estimates  of exposure-response  relations  of known health
effects from various cities have been pooled together (meta-analysis).
Health  impacts  include  eye  irritation,  respiratory  diseases,  cardiovascular  effects,  and
premature  death.  This paper,  unlike studies such as Hernandez-Avila  and others  (1995), who
focused only on hospital  costs,  assesses a wide range of health benefits of reducing air pollu-
tion:  (i) reduced cost of illness (COI);  (ii)  reduced losses  in productivity;  (iii) willingness  to
pay (WTP)  for reduced  acute  and chronic morbidity  effects;  and  (iv) willingness  to pay for
mortality effects associated with acute and chronic  exposure.
iiIn each case the WTP concept captures aspects of the value of avoiding death and illness
(for example,  the pain and suffering avoided)  above and beyond  foregone  earnings  and COI
(used here to refer to avoided medical costs).  The largest  single contributor to the benefit es-
timate  is WTP for premature  death.  Because of the debate over using WTP for valuing health
benefits,  in  particular  when  WTP  is  estimated  using  the  Contingent  Valuation  Method
(CVM), we compute the health benefits both including  and excluding this benefit category.
Specifically,  we present  three sets  of benefit estimates.  The  'high  estimate',  the  most
comprehensive  one, includes WTP to avoid illness, as well as avoided illness costs (COI) and
reduced  losses  in productivity,  to value reduced  morbidity.  Avoided  premature  mortality is
valued using WTP.  The  'central  estimate'  includes  the same comprehensive  measure  of the
value of reduced  morbidity, but values avoided premature  mortality using foregone  earnings,
a lower bound  to WTP.  The  'low estimate',  the  most conservative,  values  morbidity using
COI and productivity measures  alone and premature mortality using foregone  earnings.  The
high and central  estimates vary depending  on the  income elasticity used to transfer WTP es-
timates for morbidity and mortality from other countries to Mexico. Income elasticities  of 1.0
and 0.4 are presented; however, we view the  1.0 elasticity as our central estimate.
Table E.3  summarizes  the benefits  of each control scenario,  where results for ozone and
PM,(  are added  together.  Adding  the benefits  of these two  pollutants  is  appropriate because
the estimates for each pollutant controls for the level  of the other pollutant.  The central  esti-
mate of the  annual  benefits  of a  10 percent  reduction  in ozone  and  PM1O  is $759  million.
High and low estimates of the  value a  10 percent reduction are $1,607 million  and $154 mil-
lion, respectively.  Obtaining air quality compliance  (AQS1) offers benefits of approximately
$2 billion per year, with high and low estimates of benefits  of some $4 billion and $400 mil-
lion, respectively.
Table  E.3:  Summary  of Benefits From  Each Scenario for Ozone and  PM 10 Combined
(in  million  US$  per year,  2010 values in 1999 prices, income elasticity 1.0)
Estimates  10%  20%  AQS1  AQS2
High  1607  3184  3952  7636
Central  759  1489  1928  3580
Low  154  275  368  618
The  estimates presented in table  E.3  clearly show that the calculated benefits  associated
with air pollution  reduction provide an economic basis for expenditures to  further reduce pol-
luting emissions.  Exactly  hoW much is open to debate.  Ideally,  a study like this on economic
benefits  should  be  combined  with  estimates  of  emission  abatement  costs  to  determine  an
economically justifiable  level  of abatement.  Hence,  developing  a  cost-benefit  model is  the
next logical step.
Table E-4 presents  alternate estimates  of health benefits,  as well benefits  from avoiding
environmental contingencies,  for ozone  and PMl0 separately.  This is particularly useful as  it
iiishows  that the health benefits of PM10 reductions are roughly an order of magnitude higher
than those of ozone.
Table  E.4:  Benefits from  Reducing Air Pollution: Four Scenarios for Ozone  and PM,o
(in million US$  per year,  2010 value in 1999 prices, 3 percent discount rate)
Scenario
10%  20%  AQSI  AQS2
Income elasticity  1.0  0.4  1.0  0.4  1.0  0.4  1.0  0.4
Ozone
Health benefit estimate 1, including
morbidity (Prod.  Loss + COI  +WTP)
and WTPformortality  116  183  232  365  717  1129  794  1250
Health benefit estimate 2, including
morbidity (Prod.  Loss + COI  +WTP)
and human  capital losses for mortality  75  114  151  228  465  706  515  782
Health benefit estimate 3, including
morbidity (Prod.  Loss + COI)
and human capital losses for mortality  18  18  35  35  109  109  121  121
Environmental  contingencies benefits  36  36  45  45  45  45  45  45
PM,0
Health estimate  1,  including'
morbidity (Prod.  Loss + CO  +WTP)
and WTP for mortality  1451  2549  2903  5098  3186  5595  6793  11931
Health benefit estimate 2,  including:
morbidity (Prod.  Loss + COI  +WTP)
and human capital losses for mortality  644  1184  1289  2367  1414  2598  3016  5540
Health benefit estimate 3, including:
morbidity (Prod.  loss + COI)
and human  capital losses for mortality  96  96  191  191  210  210  448  448
Environmental  contingencies benefits  4  4  4  4  4  4  4  4
Prod. loss = Productivity losses; COI = Direct Cost of Illness; WTP = Willingness to Pay.
iv1.  Introduction
The Zona Metropolitana  del Valle de Mexico (ZMVM)  (Mexico  City Metropolitan  Area) is
one of the world's largest  urban areas  and one of the most notorious for its poor air quality.
In the  1990s, however,  efforts to control  air pollution seem to have diverted the trend. Table
1.1  shows  a decline  in  overall  air pollution  during  the  last decade  (GDF 2000).  However,
with the exception of lead,  carbon monoxide  and  sulfur dioxide,  pollution  levels are  still far
above air quality standards.
Table  1.1  Number of Days  Per Year that Ozone and  PM 10 Concentrations in Mexico City
Satisfied Air Quality Standards
1995  1996  1997  1998  1999
Ozone  41  39  43  45  65
PM, 0 273  186  212  176  345
Source: GDF  (2000).
The  Third  Air  Quality  Program  2001-2010  ("the  Program")  being  developed  by  the
Comision Ambiental Metropolitana  (CAM) includes further initiatives  to improve air quality.
These air quality efforts are expected to improve  the health of the population and also reduce
the number of environment-related  alerts in the ZMVM.  One element of the program,  and the
purpose  of this  study,  is the economic  evaluation  of the benefits  gained  from  improving air
quality.
Air pollution has  a  range of negative  effects  on human health.  It may also  affect  eco-
nomic activity when excessive levels of pollution require  Contingencias  Ambientales (restric-
tions on  environmentally  polluting  activities).  Health-related  impacts  include  eye irritation,
respiratory  diseases,  cardiovascular  effects,  and premature  death.  When a  Contingencia  Am-
bientale is declared  it limits activities  of a range  of manufacturing  industries  that  generate
emissions of air pollutants, and also restricts traffic.
In sum,  current  air pollution  exceeds  permitted  standards,  and prospects  for the future,
with some exceptions  (such as lead), will  not improve without more active  air quality man-
agement and policies designed to improve  air quality. Policy measures will be most useful if
they  can  (1)  be  defined  in terms  of specific  measures  and  the  costs  involved;  (2)  assess
changes  in air pollution  using  some  form  of air  quality modelling;  (3)  assess  and evaluate
changes in air pollution impacts; and (4) rank the measures in terms of cost-effectiveness.
The rationale  for making  air quality policies  is the  welfare  gain  from improvements  in
air quality.  This report  attempts  to assess  in economic  terms the reduced  impacts  on human
health  and economic  activity  associated with  four prespecified  air quality  scenarios  with  a
time horizon of 2010. It is limited to the impacts of ozone and PM1o because these substances
are the most important  in terms of exceeding their standards  and because  relevant health  in-
formation is not fully available for other pollutants (such as NO2).Earlier  efforts  to assess  the  benefits  of improvements  in air quality for Mexico  City by
Hernandez-Avila  and others  (1995)  estimated the direct medical  costs  and foregone  income
avoided if air quality standards were met. We  use a  different methodology  for the economic
valuation  of reduced  health risks  (see  section  6),  and  we  use recent  insights  into the func-
tional relationships  between  air quality and health  impacts.  We also deal  with the economic
benefits of avoiding Contingencias  Ambientales (the use of environmental  contingencies).
Air pollution  is the outcome  of a range of physical processes.  To understand its impacts
one needs to know (1) the spatial and temporal patterns of pollutant emissions;  (2) the chemi-
cal, physical and meteorological  processes  in the airshed;  and (3)  the effects of pollutants on
people's health, how many people are exposed to them, what economic  activities suffer from
environmental  contingencies,  and, if the scope of interest extends beyond the urban area,  how
natural systems (for example,  ecosystems and climate) are affected.
The  structure  of the report  is  as follows.  Section 2  describes  current  emissions  and air
quality management in the ZMVM.  Section  3 specifies the four air quality scenarios consid-
ered in a model of current and future air quality. Section 4 models the population exposure to
air pollution  and estimates  the  number contingency  measures  invoked.  Section  5  discusses
the functional relationship between exposure  and health, and derives exposure-response  func-
tions  specific to the ZMVM.  Section  6 covers the economic  valuation of the air quality sce-
narios  set out in section  3 in terms of both the reduced health  impacts  and the reduced  num-
ber of Contingencias  Ambientales. Section 7 discusses the results.
2.  Emissions and Current Air Quality in the ZMVM
For a quantitative  understanding  of air quality it is necessary  to have an insight  into the
spatial and temporal  pattern  of emissions.  The  present  study does  not perform  atmospheric
transport modelling as this  is outside the  scope of the study.  We will instead assume  scenar-
ios for current and future air quality and exposure (see sections  3 and 4).  To provide a context
for this study, however,  we briefly characterize  the pollution emissions that are the root of the
air quality problems  in the ZMVM.  This information  also  indicates  the available  options  for
improving  air  quality.  We  shall  also  give  a  brief overview  of current  air  quality  in  the
ZMVM. Finally,  we discuss the environmental  contingency program that is currently applied
to deal with high air pollution levels in the ZMVM.
Emissions
In recent  years  a number of different  emission inventories  have  been  taken.  Table  2.1
summarizes  the emission inventory by sector for  1996.  Table  2.2 summarizes  the emission
inventory for 1998, but excludes emissions from heavy industry and open-air refuse burning.
2Table 2.1  ZMVM  Emissions Inventory, 1996
(tons/year)
NO,  VOC  PM,0
Industry  28,666  16,279  5,700
Services  7,832  234,991  337
Transport  84,961  193,100  7,745
"Natural  sources"  a  134,673  18,072
Total  121,459  579,043  31,854
a.  Includes biogenic emissions, forest fires, and open-air refuse burning.
Source:  INE  (1997).
Table  2.2  ZMVM  Emissions Inventory, 1998
(tons/year)
NO,  VOC  PM 1 0
Industrya  22,094  17,595  3,173
Area sourcesb  8,489  270,190  1,058
Transportc  142,603  198,253  8,545
Natural sourcesd  11,802  72,670  5,800
Total  184,988  558,708  18,576
a.  Excludes heavy industry.
b.  Includes lubricant  industry, solvent emissions,  forest fires, and services sector, and others.
c.  Includes private vehicles, public transport, taxis, and trucks.
d.  Includes biogenic emissions and soil erosion.
Source: Comision Ambiental  Metropolitana (http://sma.df.cob.mx/inventario/emisiones  1998.htm
on 25 July 2000).
Ozone  air pollution  is  formed from the  emissions of NO,,  and VOCs. The amount pro-
duced depends on the amount and location of emitted pollutants; background pollution  levels;
atmospheric  chemistry;  geographical,  climatological  and  meteorological  characteristics;  and
atmospheric  transport  characteristics.  Moreover,  the  chemistry  of ozone  formation  is  quite
complicated and nonlinear:  under certain conditions  an increase in NO,  emissions  can reduce
ozone concentrations.
The  origins  of particulate  pollution  (PM1o)  are less  clear.  PM 1O  may be  emitted  directly
or  formed from  SO2 and NO,  reacting with  other  substances  in the atmosphere  (secondary
particle  formation).  Likely  sources  of  directly  emitted  particles  include  building  and
construction  (road construction),  diesel trucks and buses, forest fires, open-air refuse burning,
some  manufacturing  industries,  and  resuspension  of road  dust.  The  relationship  between
emissions  and concentrations,  however,  is not straightforward  due to  secondary particle  for-
mation.  The ambient  concentration  of air pollutants  depends  on the  amount  and  location  of
emissions;  the  source dependent physical  characteristics  of the emitted  PM1O  and  PM1O pre-
3cursors such  as SO 2 and NO,'; background pollution  levels (especially of ammonia);  atmos-
pheric  chemistry;  geographical,  climatological  and  meteorological  characteristics;  and  at-
mospheric transport characteristics.
Air Quality and the Programa de ContingenciasAmbientales(PCA)
Most air quality information comes from measurement stations across the area-the Red
Automatica de Monitereo Atmosferica (RAMA)-that compile time-averaged  concentrations
(see  figure 2.1). The annual  reports usually present this information  in frequency  tables giv-
ing the percentage  of a year that a certain concentration  occurred, or as a single annual aver-
age.
Day-to-day air quality data available  on the Internet include daily maximum concentra-
tions for five pollutants-PM1 O,  ozone,  SO2,  NO,, CO-and an ultraviolet  (UV)  index)  for
five  zones2:  downtown,  Northwest,  Northeast,  Southwest  and  Southeast.  These  concentra-
tions are expressed  in IMECA points (Indice Metropolitana  del Calidad  del Aire). Table 2.3
shows how concentrations relate to the indicator points (100 = standard).3
Figure 2.1  Measuring PM 10 and Ozone  Concentrations across the ZMVM
v  Pla  Stl.on.
Z  .1nII1p.IkI..  and  D.I.g.lon-
If one would consider PM2 5-a smaller mass than PM1O-emissions  of SO2 and NO.  become more important
since these substances can  be converted  into particulate  matter (PM1.0) in the  atmosphere.  Furthermore,  NO.  and
VOCs can be attached to existing particulate matter in the  atmosphere.  The indications are that these  small parti-
cles  have  disproportionately  large  health  effects.  However,  given  the lack of air quality information  on  PM2.5
(and appropriate  epidemiological data) it impossible to take account of this.
2 http://sima.cor.mx/sima/df  (April 2000).
3  For ozone, the IMECA  indicator is  proportional  to  ozone concentrations.  For PM 1O  an IMECA number  fol-
lows from linear interpolation  between the values indicated  in the table.
4Table  2.3  The IMECA Indicator System for PM 10 and  Ozone
IMECA  points  100  200  300  400  500
PMl 0 [ig/m3 (daily average)  150  350  420  500  600
Ozone ppm  (daily 1-hr.  maximum)  0.110  0.232  0.355  0.477  0.600
Source:  INE (April 2000) at http:///www.ine.gob.mx/dggia/indicatores.
Figure 2.2 shows the trend in the IMECA points between  1990 and 1999 for ozone and
between  1995 and  1999 for PM 1O.  Table 2.4 shows the number of days per year satisfying air
quality standards.
Figure 2.2  Daily Average  Trends  in the ZMVM  for Ozone and  PM 10
Ozone, daily average  1-hour maximum
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300  - - _  _  _  _  _  _  _  _  _  _  - _  _
100  164.  1180  1652  173.2  169.  -4  - 15.1  9
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1990  1991  1992  1993  1994  1995  1996  1997  1998  1999
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PM 10, daily average
250
200  4_  __-_
E100Xf  -- L  100.3  *98.6  - 102.8  1
50  l_l____  _.  _
0
1995  1996  1997  1998  1999
-Maximum  * Average  -Minimum  AQS <= 100  IMECA units
Source: SMA  (1999).
5Table 2.4  Number of Days Ozone  and PM,0 Levels Satisfied Air Quality Standards
1990  1991  1992  1993  1994  1995  1996  1997  1998  1999
Ozone  37  12  34  41  21  41  39  43  45  65
PM 10 --  =  --  273  186  212  176  345
Source: SMA  (1999).
For the period 1995-99,  the highest value  for ozone-0.349 ppm-was measured at the
Pedegral  station, which is  located in the Southwest  zone.  Ozone air pollution  at this  station
exceeded the standard for 276 days. The least polluted station was Chapingo in the Northeast,
with a daily 1-hour maximum concentration of 0.210 ppm .
Air quality standards  for PM1O include a daily average  (150 ,ug/m3) and an annual  aver-
age (50 ,ug/m3). All stations violated both standards  apart from the annual average  standard at
the Pedregal  and  Coacalco  stations  (formerly  Villa  de  las  Flores).  The  highest concentra-
tion-a daily maximum of 335  11g/m 3 (190 IMECA)-was  observed in the eastern zone at the
Nezahualcoyotl  station.  The maximum annual  average of 94  tg/m3 was observed at Xalostoc
station. This station has traditionally recorded the highest particulate matter concentrations  in
the  metropolitan  area,  exceeding  particulate  standards  58  days  per year  (16  percent  of the
year).  As a result,  in  1995 about  1.2 million people were exposed at least once a year to PM1 O
concentrations  above 300  Ag/m 3, the trigger for a Phase I contingency (see table 2.6).
If  air pollution  goes above  certain  levels  in one  of the  five zones a  PCA is invoked  (a
contingency program). Table 2.5 describes the three levels of action:  Precontingency,  Phase I
contingency,  and Phase II contingency.
Table 2.5  The Environmental Contingencies  Program
Target  Precontingency  Phase I  contingency  Phase llcontingency
Public health  Suspend outdoor  Epidemiological surveillance  Suspend activities in
sport activities in  and communication of rec-  public offices, recrea-
schools and  ommendations to address  tional activities and
parks.  health risks.  public services.
Transport sector  Restrict traffic (no circulation  Suspend use of all
of hologram 11  vehicles  hologram 11  vehicles
every other day).  and 80%  of public ser-
Suspend  use of publicly  vice vehicles.
owned vehicles by 50%.
Improve traffic circulation.
Industry and  services  Reduce certain industrial ac-  Reduce industrial activ-
tivities 30-40%.  Suspend  ity by 50%.
fuel distribution activities,
red brick fabrication, and the
thermoelectric power plant
Jorge Luque.
Public services / in-  Suspend maintenance  of urban  infrastructure.
frastructure mainte-
nance
Additional actions  Surveillance and  control of fires in natural and  agricultural areas I landfills.
Source: SMA (http://sma.df.gob.mx).
6Precontingencias  (precontingencies)  apply to  the zones where the corresponding  thresh-
old  is  exceeded.  For  ozone  and the  ozone-PM1 O combination,  Phase I  applies  to the  entire
ZMVM,  while  for  PM1o alone  Phase  I  applies  only to  the  zone where  the  threshold  is  ex-
ceeded.  If the  situation persists,  however,  the contingencia is extended to the entire ZMVM.
Phase II applies to the entire ZMVM irrespective of which zone exceeds the threshold.4 Table
2.6 gives the air quality threshold levels applied since May 1998.
Table  2.6 PCA Threshold Air Quality Levelsa
Levels  Ozone (IMECA)  PMo 0 (IMECA)
Precontingencia  200-240  (0.233-0.281  ppm)  160-175  (270-300yg/rm 3)
Phase 1  240-300  (0.281-0.355  ppm)  175-300  (300-420  pg/M3)
Phase II  > 300  (>0.355  ppm)  > 300  (>  420 Pg/M3)
a. Since May 1998.
3.  Air Quality Modelling
Three  strands of science  are  combined to address  the research  question of this report:  air
quality and  exposure  modelling,  epidemiology,  and economics.  This section  focuses on  air
quality modelling of current and future  scenarios. The next section deals with exposure mod-
elling. Figure  3.1 shows the basic elements of the two sections.
Figure 3.1  Overall Approach for Exposure Modelling
Air quality at  Population
Measurement  Stations  Economic  activities
Model  of air quality
across the ZMVM  Exposure  model
4For more information go to http://sma.df.gob.mx/contingencias2OOO.
7Modelling of Current Air Quality
The starting points for modelling air quality are the air quality measurements  at specific
locations in the ZMVM.  Figure 2.1  shows the RAMA air quality measurement network.5 The
empirical data from the measurement  stations is used to derive an air quality data field for the
entire ZMVM.  Since the use of an emission database and an atmospheric transport model are
beyond the scope of this study6, we apply a simple approach to generate the air quality fields.
We  use measurements  at the stations between  1995  and  1999,  spatial interpolation  in a  geo-
graphical  information  system  (GIS),  and  take  the  average  over  the  institutional  units  (16
delegations in FD) and 28 municipalities in the State of Mexico.
Because the measurement  stations tend to be  located in areas with high levels of pollu-
tion,  information  from  relatively  good  air  quality  areas  is  patchy.  Therefore,  interpolating
only on the basis of measured data could give unrepresentative  results.  We avoid such inter-
polation results by assuming pseudo  air quality data at locations  where  low pollution  is ex-
pected.7
Another difficulty was  selecting  a reference  air quality year  for comparison  with future
air  quality.  Given  the  variability  of meteorological  conditions  the  reference  air pollution
year-represented  as  an  air quality  frequency  distribution-was  derived  from  the  distribu-
tions  for  1995-99.  This  reference  distribution  preserves  the  following  three baseline  statis-
tics: the average over the five-year interval; the standard deviation over the five-year interval;
and the maximum  concentration in the five-year  interval (see Cesar and others 2000 for more
details).
We developed  the following distribution metrics for air quality:
*  for ozone, a daily 1-hour maximum,  a daily maximum  8-hour running average,  and a
daily average;
*  for PMIo,  a daily average.
Figure 3.2 presents estimates based on the regionally differentiated air quality models for
annual  average  ozone  (daily  1-hour maximum)  and  PM1o (daily  average)  over the  ZMVM
during  1995-99.
5 The network has  19 ozone stations and 10 PM1o stations.
6The  Germnan  Fraunhofer  Institute  developed  such  a model  for CAM during  the period of the present  study.
Unfortunately,  results of this development  were not (yet) usable for the present project.
7We consulted experts to make the best estimate of air quality across the ZMVM.
8Figure  3.2  Regionally Differentiated  Model for Air Quality by Region, 1995-99
(for 16 delegations in FD and 28 municipalities in the State of Mexico)
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Modelling Future Air Quality
The previous  section developed  a baseline  for air quality  for the ZMVM  thought  to be
representative of the end of the 1990s.  Since a program to improve air quality would typically
take some years to show results, we chose the  year 2010 as the reference  year for the  future.
So two research questions arise:
*  What reference or business-as-usual  scenario  for the air quality in 2010 do we use, assum-
ing no air quality policy beyond current measures?
*  What future  air quality scenario  do we want  to evaluate, assuming  some air quality policy
beyond current measures?
The Future Reference Scenario
For an assessment of future  air quality one needs insight into  factors that determine  air
quality.  The main determinants  are emissions and climate,  although the latter is not likely to
change significantly  over the next  10 years.  So, the key question is "How  will emissions de-
velop  over the next decade?"  In  our speculations  about  future  emissions we deal  separately
with ozone and PM 1 o, since the origins of these two problems are for the most part unrelated.
Ozone pollution  is generated  in the presence of NO,  (nitrogen oxides) and VOCs (vola-
tile organic  compounds  or hydrocarbons)  in the atmosphere,  and depends  on  geographical,
climatological  and  meteorological  conditions.  Most emissions  of NO,  and VOCs-50  to 75
9percent-come  from  the  use of gasoline  vehicles  and  associated  gasoline  distribution  sys-
tems.  As  table  3.1  shows,  emissions  standards  for new gasoline vehicles  have helped to re-
duce  emissions. The  share of modem  cars  with three-way catalysts  (electronic  systems)  has
risen to over  10  percent of the  total Mexican  fleet of gasoline  cars (about  70 percent of all
cars).  In the ZMVM  all new gasoline cars are equipped  with catalytic  systems.  According to
SMA  (1999), however,  32 percent  of the  cars in the  ZMVM  are pre-1980  models.  And we
know that emissions  from pre-1986  cars are ten times greater than  1999 cars. Hence, total fu-
ture emissions depend on the rate at which old cars are replaced with newer models.
Table 3.1  Environmental  Characteristics of Cars  Sold in Mexico around  1998
Year/model  Features  Percent of vehicle fleet
Pre-1986  With carburator  37.2
1986-1992  Fuel injection  23.8
1992-1993  Catalytic converter  28.6
1994 and after  Full electronic systems  10.4
Total  100.0
Source: Mexican Association of Vehicle Distributors  (April 2000) as cited at
www.tradeport. orQ/ts/ countries/mexico/isa/isar0013.html.
As the composition of the future vehicle  fleet in Mexico  City is unknown,  it is assumed
here-in  the absence  of an  integrated  model  on  emission  projections  for  2010  for mobile
sources-that  emissions  in  2010  will  equal  those  of 1998.  This  could  be  the  case,  for in-
stance,  if all  improvements  in vehicle  emissions  were exactly offset by the growing  impor-
tance of road transport  in the ZMVM.  This would also hold  for VOC  emissions. Hence,  in
the absence  of more  detailed  information  on  emission  patterns,  we  assume  that NOx  and
VOC emissions  will  be the same  as at the end of the  1990s.  Once  again, we note the enor-
mous uncertainty of baseline predictions.8
Table 3.2  Main Assumptions on Reference  Scenario
Pollutant  Main observations  Result
NO,  and  There are two opposing trends:  (i)  increase in  Due to lack of information  it is as-
VOCs  cars,  buses and other pollution sources; (ii) the  sumed that the baseline situation in
emissions per unit is decreasing over time. The  2010 is equal to current conditions.
resultant of these two trends is  inconclusive.
PM,0 Origins of PM10 are uncertain. Trends in meas-  Due to lack of information it is  as-
ured air quality (since 1995) are inconclusive.  sumed that the baseline situation in
2010 is  equal to current conditions.
8As mentioned  in the previous section,  meteorology is an important explanatory variable for actual  air quality,
but  is unlikely to change  during the time horizon  of this analysis.  We, therefore,  assume meteorological  condi-
tions in 2010 to be similar to the meteorological conditions of the 1995-99  reference  air pollution year.  Economic
variables are equally uncertain  and different growth patterns will greatly influence the actual future emissions.
I0Changes  in PM 1O  emission sources and their contribution to air quality  is even more un-
clear.  Relevant  sources  of directly emitted  particles  include  building  and  construction  (for
example road  surface works),  diesel engine vehicles  (about  30 percent of all vehicles  (SMA
1999)),  forest fires, industry,  and open-air refuse burning. Measurements  of PM1o since 1995
(the year in which  continuous  PM 1o air quality measuring started)  do not indicate a trend, al-
though  in  1999 the number of days that  standards were violated were  the lowest in the  five-
year period.  In the absence  of any concrete trend data  or integrated model  on emission pro-
jections  for 2010  for fixed and mobile  sources,  we assume  the reference  case in 2010  to be
equal to the  1998 baseline air quality. We note the arbitrariness of 2010 baseline.
The Future Scenarios
To  examine  the implications  of different levels  of pollution  control  we  developed  four
alternative 2010 scenarios  in addition to the 2010 reference  scenario:
*  a  10 percent air pollution reduction scenario;
*  a 20 percent air pollution reduction scenario;
*  an  air quality  standard  compliance  scenario  assuming  air  quality would  improve  to  the
standard (50 JIg/M3 for PMI0 and 0.11  ppm 1-hour maximum for ozone)  in all locations  in
the ZMVM-the AQS 1 scenario;
*  an air quality standard compliance  scenario superimposing the needed percentage  decrease
in concentrations  in the most polluted  areas  (Xalostoc  for PM 1O  and Pedregal  for ozone)
across  the ZMVM  (68  percent and  47  percent reduction  in ozone  and  PM1o concentra-
tions, respectively)-the  AQS2 scenario.
To enhance  the potential plausibility of the scenarios, we compared them with air quality
trends for the South Coast Air Basin of California (see box 3.1). The trends for this area show
a decline  in maximum  ozone  concentration  of 24  percent  in  10  years  due  to  strict controls.
Similarly,  the  PM 1O  annual  average  decreased by 40 percent,  but maximum PMlo  concentra-
tions remained the same.  Hence, the first two  scenarios proposed seem plausible but the third
and especially fourth scenario would be  very difficult, but not impossible,  to  achieve. We do
not consider the policies needed to achieve the concentration reductions in this study.
IIBox 3.1  Air Quality Trends for the South Coast Air Basin of California
Year  Ref  Ozone  _  Ref  PM1o
Year  1 hour max  Stndrzd  8 hour max  Stndrzd  Year  24 hour max  Stndrzd  AA  Stndrzd
oDrn  to  WO  DOM  to YO  ua/m3  to YO  ua/m3  to YO
1980  0  0.49  1.00  0.34  1.00
1981  1  0.39  0.80  0.28  0.84
1982  2  0.40  0.82  0.27  0.79
1983  3  0.39  0.80  0.26  0.77
1984  4  0.34  0.69  0.25  0.74
1985  5  0.39  0.80  0.29  0.86
1986  6  0.35  0.71  0.25  0.75
1987  7  0.33  0.67  0.21  0.62  0  219  1.00  73  1.00
1988  8  0.35  0.71  0.26  0.77  1  289  1.32  82  1.11
1989  9  0.34  0.69  0.25  0.75  2  271  1.24  81  1.11
1990  10  0.33  0.67  0.19  0.58  3  475  2.17  67  0.91
1991  11  0.32  0.65  0.20  0.60  4  179  0.82  65  0.89
1992  12  0.30  0.61  0.22  0.65  5  649  2.96  62  0.85
1993  13  0.28  0.57  0.20  0.58  6  231  1.05  58  0.79
1994  14  0.30  0.61  0.21  0.62  7  161  0.74  56  0.76
1995  15  0.26  0.52  0.20  0.60  8  219  1.00  52  0.71
1996  16  0.24  0.49  0.17  0.52  9  162  0.74  52  0.71
1997  17  0.21  0.42  0.17  0.51  10  227  1.04  56  0.77
Parameter  Ozone  PM10
1 hour max  8 hour max  24 hour  max  AA
R Square  0.87  0.78  0.06  0.81
Obs  18  18  11  11
Intercept  0.88  0.88  1.53  1.07
P-value  >0.001  >0.001  0.004  >0.001
m  -0.0238  -0.0216  -0.0498  -0.0400
P-value  >0.001  >0.001  0.475  >0.001
Annual red.  -2.4%  -2.2%  -5.0%  -4.0%
Decade red.  -24%  -22%  -50%  -40%/o
Source: California Air Resources  Board (p. 90,  1999).
Although  the  definition  of baseline  air quality in 2010  is highly uncertain,  the benefit
analyses  that follow are valid for the reductions  in ambient air pollution associated with each
scenario.  This is because the dose-response  functions used to quantify health benefits and the
economic  values  applied  to these  benefits  are  independent  of baseline  levels  of air pollu-
tion-they depend only on changes in ambient pollutant concentrations.
4.  Exposure  Modelling and Contingency Estimates
This  section  describes  both the  modelling of exposure  and the  estimation  of environ-
mental  contingencies  (that  is,  alerts).  First,  exposure  of the  population  to pollution  is mod-
elled by combining the air quality maps  (section 3) with information on population distribu-
tion.  This model  will be used to estimate  the health  impacts of air pollution  in the next sec-
tions.  Second, we estimate  the number of environmental  contingencies  declared  to value the
economic  cost of these alerts (in section 6).
12Population
The  Mexico  City Metropolitan  Area (with a population of 17  million in  1995  (Instituto
Nacional de Estadistica, Geografia e Informatica, INEGI,  1997) is composed  of the Federal
District (containing Mexico  City and its 8.5 million inhabitants)  and part of the State of Mex-
ico.  Demographic  information  used  for the population  distribution was obtained  from Mexi-
can National  Institute of Statistics,  Geography  and Information  (INEGI).  Figure  4.1  presents
a population distribution  map of the ZMVM.  The GIS working  group  at the Federal  District
Government  provided  political  boundaries  and  geographic  definitions.  Each  locality  (repre-
sented by a point) is assigned to a municipality  (in the  State of Mexico)  or to a delegation  (in
the Federal  District).
Figure 4.1  Population Map for ZMVM  by Municipality, 1995
(in  the State of Mexico)  or Delegation  (in the Federal District)
J  -
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Exposure of the Population
By combining the map of population  distribution  and the maps of air quality it was pos-
sible  to  assess exposure  of the population  to air pollutants.  This assessment of pollution  ex-
posure  should correspond with the format of exposure  defined  and used in the epidemiologi-
cal  studies  that  our  exposure-response  models  are based  on  (section  5).  Exposure-response
relations  are  constructed  from  epidemiological  information  and  air  quality  measurements
made  at  monitoring  stations.  The  statistical  exposure-response  relationships  reflect  several
factors  in the cause-effect  chain between air quality and health effects.
13One of these factors  is actual  exposure  and inhalation.  This  element  is important since
indoor air quality  differs  greatly from  outdoor  air quality, and an individual's  behavior de-
termines  what  he/she actually inhales.  In epidemiological  studies  (see  meta-analysis  in  sec-
tion  5), however,  it is assumed that exposure is proportional  to measured air quality at a spe-
cific  outdoor  air  quality  measurement  station.  Actual  exposure  will,  however,  differ  from
measured concentrations,  depending on human activity patterns. Exposure-response  functions
incorporate  the behavior of people in the particular study area and we need to assume that the
behavior of people in Mexico City is similar to that of the people in the study areas where the
epidemiological  studies  are performed.  Also other factors,  such as state of health, age,  diet,
and so forth may lead to differences  in the exposure-response  functions in different locations.
Due to the lack of information  and knowledge  as to how these characteristics  influence  the
estimated functions we have to assume there are no differences between the characteristics  of
people represented in the epidemiological  studies and those living in Mexico City.
For exposure  to PMIo, the metric  we use is  the annual  average  of the 24-hour  average
concentration  in an area.  For exposure  to ozone, the metric we use is the  annual  average  of
the daily  1-hour maximum  concentration  in an area (see Cesar and others 2000 for more de-
tails.)
Figure 4.2 summarizes population exposure  in the  1995-99 reference air quality scenario
we developed in the previous section.  The baseline scenario  for exposure  can be summarized
by computing population-weighted  exposure  for each pollutant.  For PM1o  and ozone  this is
64.06  pLg/m 3 /person and 0.114 ppm/person,  respectively.  The  10 percent  reduction scenario
would lead to a reduction of 6.41  ,ug/m 3 PM,W/person  and 0.0114  ppm ozone/person,  respec-
tively.  A 20 percent reduction would double this figure. The AQSl  scenario would result in
reduced  exposures  of 14.06  p.g/m3/person and  0.0702  ppm/person  for PM1o and ozone,  re-
spectively.  The AQS2 scenario  would result in the reduced exposures of 29.99 jIg/m3 /person
and  0.0778  ppm/person  for PM1o and ozone, respectively.  These  results  are  summarized  in
table 4.1.
This table indicates that for PM1o, a compliance strategy aimed at achieving the air qual-
ity standard  in each  area  and no further  air quality improvement  would have only a slightly
higher benefit than a uniform  20 percent reduction in the annual average.  Hence, an emission
abatement strategy should target sources in highly polluted and populated areas of the metro-
politan area.
14Figure 4.2  Reference  Scenario for Population Exposure  to Ozone and  PM 10
for the ZMVM,  1995-99
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15Table  4.1  Reduction in Population-Weighted  Exposure for the Analyzed  Scenarios
Population weighted  Population weighted
exposure to PM 1O  Exposure to ozone
Scenario  (pg/rM
3 /person)  (ppm /person)
10 percent exposure reduction  6.41  0.0114
20 percent exposure reduction  12.81  0.0227
AQS compliance in each area-AQS1  14.06  0.0702
AQS compliance in worst area-AQS2  29.99  0.0778
Environmental  Contingencies
This section estimates  the number of times a contingency is declared;  that is, the number
of days that ozone or PM 1O  concentration measured  at each station  exceeds the relevant  stan-
dard  for the  reference  scenario and  for each of the  future  scenarios.  Implicitly  it is assumed
that a contingency is declared if the measured concentration  is above the concentration  levels
stated for the contingency  (see section  2 for  details  on the Contingencias  Ambientales pro-
gram).  In practice  this is not always the case,  for instance when air quality on a specific day
is expected  to improve considerably  because of changing  meteorological  conditions.  There-
fore,  our predictions  give an upper estimate of the number of contingencies.
The  highest  ozone  concentrations  in  the  period  1995-99  have  been  observed  at  the
Pedegral  station.  The  five-year  composite  frequency  distribution  of  the  highest  daily
1-hour maximum  ozone concentrations  for the whole  ZMVM is shown in figure 4.3 together
with the  future  scenarios (see  section 3).  Contingencia I is triggered at IMECA=240,  which
corresponds  to 0.281  ppm. According  to the frequency distribution a contingencia  I would be
invoked  for  10  days,  and a contingencia II would be invoked  for 0 days.  (In the  10  percent
reduction  scenario:  2  days  for contingencia I. In the 20 percent  reduction  scenario:  0  days).
Noted that the threshold  levels from  May  1998  are used to  make this calculation.  Table  4.2
gives the results based on pre-May  1998 threshold levels.
Figure 4.3 Cumulative  Frequency Distribution of Pedegral  Station and Ozone  Air Quality
Scenarios,  1995-99
Station Pedregal
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16Table  4.2 Days above  Ozone  Daily 1-hour Maximum  Standards and Contingency Stages
Ozone (ppm)  Baseline  10 % Red  20%  Red  At standard
>0.355  0  0%  0  0%  0  0%  0  0%
>0.281  8  3%  2  1  %  0  0%  0  0%
>0.233  60  18%  25  8%  5  1  %  0  0%
>0.110 AQS  319  87%  306  84%  285  79%  0  0%
The  highest  frequency  distribution  for  the  PM1O daily maximum  concentration  in  the
ZMVM shows that air quality at that specific place would trigger one contingencia (see table
4.3  and  figure  4.4).  The  highest  values  are  measured  at  the  stations  Nezahualcoyotl  or
Xalostoc.
Table 4.3  Days above the PM,0 Daily Maximum  Standards and Contingency Stages
PM 10 (pg/m3)  Baseline  10%  Red  20%  Red  At standard
>420  0  0%  0  0%  0  0%  0  0%
>300_Neza  1  1  %  1  0%  0  0%  0  0%
>270_Xal  2  1  %  1  0%  0  0%  0  0%
>15OAQS  87  16%  59  12%  34  7%  0  0%
Figure 4.4  Cumulative Frequency Distribution of Xalostoc Station PM,0 Air Quality
Scenarios, 1995-99
Station Xalostoc
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175.  The Physical Effect of Air Pollution
This section deals with assessing the effect of improvements  in air quality in the ZMVM
on  human  health  and  environmental  contingencies.  We  begin  with  an  introduction  to  the
health  effects  of ozone  and PM10. Then  we  discuss  the  relationships  between  public  health
and air quality (exposure-response  relations) and quantify the health benefits  of the  air qual-
ity improvement  scenarios in physical  terms.  The economic  benefits of these health benefits
and of contingencies will be quantified in section 6.
Effects of Ozone and PM 1o  on Health
Not all air pollutants have the same capacity to damage human health.  The differences in
toxicity are due to the physical and chemical  properties of the components  of pollution. First,
we briefly  discuss the  types of health effects  caused by exposure  to air pollution.  Then  we
describe  the properties  of PM1o and  ozone  as  they  relate  to toxicity.  More  details  can  be
found  in Cesar  and others (2000).  In the  second  section we  discuss the development  of the
exposure response functions that are used in this study in more detail.
Health Effects  Due to Short- and Long-  Term Exposure to Air  Pollutants
Susceptibility to air pollution  exposure varies  greatly among individuals.  Individual risk
is determined  by genetics,  age, nutritional  state, presence  and severity of respiratory and car-
diac  conditions, and the use of medications.  The  variability in the estimates  found in epide-
miological  studies may reflect  these  differences  in the populations  studied. A good  example
of variation in individual risk occurs in the evaluation of maximum expiratory flow in healthy
children,  children  with minor respiratory  disease  and those  with  asthma,  with  and without
pharmacological  treatment,  and all  exposed to various environmental  pollutants.  The results
show  an association  between  exposure  and disease  only in children with asthma  under phar-
macological  treatment,  in other words, those children who are most seriously ill (Roemer and
others  1999). Genetic susceptibility  is another factor that could be associated with respiratory
diseases (Moller,  Schuetzle,  and Autrup  1994). Age  is an important factor as well, with pre-
adolescents  (<13  years)  and  the  elderly (>65)  at  greatest  risk  (Wilson  and  Spengler  1996,
Ghio and others 1999).
Toxic effects attributable to short-term  exposure to high levels of air pollution (hereafter
"acute  effects and acute  exposure")  vary widely.  Episodes  of high pollution and the associ-
ated increases in diverse respiratory and heart diseases and death have been reported since the
beginning  of the industrial  revolution.  The  most serious  acute  effect  is mortality.  Many re-
ports  describe  an  increase  in  total  mortality  (not  including  accidental  death)  associated
mainly with exposure  to particulate  matter (PM),  ozone, and sulfates.  (Schwartz  1994a, Wil-
son and Spengler 1996).
Many studies  report increases  in mortality due to respiratory complications,  and this re-
lationship  can obviously be related to exposure  to air pollution.  Many reports  also claim  an
increase  in death due  to  cardiovascular  disease,  which  would  also  imply  an  indirect  effect
18from air pollution. Both causes of death are associated  with exposure  to PM, ozone, and sul-
fates.  Mortality attributable  to  exposure to air pollution occurs mainly in individuals who al-
ready suffer from cardiac  and/or respiratory  diseases. Increased mortality  in these groups  oc-
curs within one to five days following  the hazardous  exposure  (Schwartz  1994a, Wilson and
Spengler  1996).
Short-term exposure to high levels of air pollutants  is also associated with diseases of the
respiratory  tract, both  upper  and lower:  bronchitis,  pneumonia,  chronic  obstructive  pulmo-
nary disease, and cough with phlegm.  Symptoms aggravated by exposure to certain pollutants
such as ozone  and PM include asthmatic attacks,  cough without phlegm,  and wheezing (Wil-
son and Spengler  1996, Ghio  and others  1999).
Episodes of extremely high pollution documented  in cities  around the world have dem-
onstrated  the  consequence  of human exposure  to  high concentrations  of air pollution.  These
episodes,  however,  occur sporadically,  whereas  exposure  to  low concentrations  of pollutants
over long periods of time is a daily phenomenon.  Recent  studies have focussed  on establish-
ing the effects of long-term exposure to low levels of air pollutants.
Health  effects  due to  long-term,  low-level  exposure  to air pollution  (hereafter  "chronic
effects  and chronic  exposure")  are  similar to  those reported  for short-term  exposure  to high
levels of air pollution.  A synthesis of the available  information  concerning  chronic  exposure
is an extremely  complex task because many different  factors can cause  the same  symptoms.
There  are  several  reports  of increased mortality related  to  chronic  exposure,  however,  most
cases involve  mainly  elderly individuals  for whom  respiratory and  cardiovascular problems
are already the principal cause of death (Pope  and Dockery  1999).  Increased respiratory dis-
eases (such as bronchitis) have also been reported as associated with chronic  exposure.
In both acute and  chronic  exposure  to air pollutants,  populations  are  exposed to a  com-
plex  mixture  of compounds  whose  combined  toxic  effects  could  differ  from  that  of each
compound alone. A study performed  on volunteers exposed to ozone with and without preex-
posure  to  H2SO4 showed that the  preexposed  group  suffered more  severe toxic  effects  than
the group that was not preexposed  (Wilson and Spengler  1996).
Particulate matter and ozone are often correlated  spatially and over time, making it diffi-
cult to separate the effects of the individual pollutants. The mixture of PM1O  and ozone, how-
ever,  has proven more  toxic  than the  individual  compounds  alone (Katsouyanni  1995).  Un-
fortunately models  and protocols  to  analyze  the  different  interactions  among  environmental
pollutants  are not yet  available  (Samet  and Speizer  1993).  Thus,  it is not  clear  how much
each  pollutant  individually  influences  elevated  mortality  and  morbidity  rates.  As  a result
some cost-benefit studies have chosen to use one index air pollutant rather than estimating ef-
fects for multiple air pollutants  individually and then adding their effects to get a total air pol-
lution  effect.  Focusing  on a  single pollutant provides  a conservative  approach  to  estimating
air pollution effects.  In fact, recent analyses (for example Thurston and Ito  1999) suggest that
ozone and PM air pollution effects  are relatively independent,  since controlling  for one pol-
lutant has only modest effects  on the concentration-response  of the  other. Thus, use of a  sin-
gle  index pollutant  underestimates  the overall  public  health  effects and monetary  valuations
19of air pollution changes.  Given that the  effect of ozone on mortality  independent of particu-
lates is still being debated, we re-evaluated the effect of ozone restricting the analysis to those
studies that controlled for particles in the statistical analysis.
Properties of  PM, 0and Ozone
Aerosol  air pollutants  (molecular aggregations)  have been  shown to be more toxic than
gases.  This  is  because  gaseous  compounds  are  eliminated  by the  respiratory  system  much
more  easily than  aerosols,  which are  rapidly  deposited or absorbed.  (Wilson  and  Spengler
1996).
PM 1O In the field of air pollution epidemiology,  there is now much more interest in the
study of PMlo and PM 2.5 particles, and the organic and inorganic  compounds in them (Wilson
and Spengler  1996, Pooley and Mille  1999). The particles produce toxic effects  according to
their  chemical  and  physical  properties.  Their  effects  on  susceptible  individuals  are  much
more  severe  than  those  produced  in  normal  individuals  (Schlesinger  1995,  Wilson  and
Spengler  1996).
The extent  of particle penetration  into  the  respiratory  system is  determined  by particle
size. Only particles less than  10  p.m  in diameter enter the respiratory system. This is the rea-
son for focusing on PM1o (particles  less than about  10  [im).9 Once particles have entered  the
respiratory  tract,  depending  on their  size,  they  can accumulate  in different  sites.  Evidence
suggests  that  many of the  health  effects  associated  with  PM1o can  be  attributed  to  even
smaller particles (Pope and Dockery 1999,  Ghio and Samet 1999).  Since, however, most epi-
demiological  information  refers  to  PM10,  and  for  the  ZMVM  there  is  little  air  quality
information on smaller particles,  we restricted our analysis to PM1O.
The  chemistry  of suspended  particles  complicates  empirical  epidemiology enormously
and has not been analyzed in detail  yet, so little epidemiological  evidence is available  on the
influence of the  chemical composition  of particles.  Since little is known about the chemistry
of PM1o found in Mexico City, this aspect is not accounted  for. This contributes to the uncer-
tainties associated with exposure-response  modelling.
Ozone.  Ozone  is a poorly soluble but highly reactive  gas.  "Bad"  ozone  (as  opposed to
"good" ozone  in the stratosphere) is mainly produced  in the troposphere (ground  level) by a
series  of sunlight-driven  reactions  involving  oxides  of nitrogen  and  volatile  organic  com-
pounds.  Inhaled ozone  is partially depleted  in the upper  airways but a major fraction reaches
the lower airways.  In  the body ozone  can  react with uric  acid, which  is  secreted  by human
submucosal airway glands  and is present in near millimolar/liter  (mmolI1)  concentrations  of
nasal surface  liquid. Pryor and his colleagues  have proposed that some of the toxic products
of the latter reaction (hydroxyhydroperoxides,  hydroxyaldehides)  are  important mediators  of
ozone  effects  on  underlying  epithelium.  Bromberg  (1999)  has calculated  that  ozone  per se
does not even reach the epithelial cell apical membrane in conducting  airways.
9 Actually, the metric is not the size, but the aeolic behavior of particles, as measured  in equipment that mimics
the human respiratory system.  This metric comes close to size.
20The proportion of ozone  uptake attributed to surface liquid dynamics decreases  progres-
sively as  a  surface  liquid thins and its  reactivity with  ozone  diminishes,  so  that the  highest
epithelial  tissue  dose  is  predicted  for the terminal bronchiole-respiratory  bronchiole  region,
which  is,  indeed, a  site of damage  in ozone-exposed  animals.  Bronchoscopic  sampling along
airways also indicates that a substantial fraction  (35 percent)  of orally inspired  ozone is taken
up in the upper airway and trachea and that ozone in exhaled air is limited to the initially ex-
pired volume representing  airways dead space (Bromberg  1999).
The toxicity of ozone inhalation in large airways is supported by evidence of ciliated cell
loss and increased  epithelial mitotic  index in  small  animals,  netrophilic  inflammation  in hu-
mans,  increased  bronchial  artery blood  flow  in  sheep,  and  by the  symptoms of cough  and
substernal pain exacerbated by deep inspiration in humans (Bromberg  1999).
Development  of Exposure-Response  Models for Mexico City
Meta-analysis
Although  the  number  of published  studies  on  the  health  effects  of air  pollution  has
grown during the  past decade,  specific  studies of the  ZMVM are  still limited.  We,  therefore,
decided  to summarize  relevant  international  and national  published  reports through  a  meta-
analysis, which combines the results from various studies to identify consistent patterns.  Due
to the rapid  growth of the field of epidemiology  since  the  1960s,  the number of publications
is  overwhelming  and  a  classical  narrative  review  is no  longer  appropriate  for summarizing
findings.  Despite  limitations,  statistical  analysis  of compiled  published  results  has  become
more common when dealing with an extensive offering of differing and inconclusive  results.
Identirication,  Selection and Classfication  of  Bibliographical  Information
The  meta-analysis  involved an  exhaustive  search of published studies  on human health
effects due to exposure to ozone and PMIo using Medline,  Pubmed, Biomed-net and Aries da-
tabases.  Manual  library searches  examined mainly Mexican publications.  Not all the biblio-
graphic material collected was appropriate for the statistical analysis.
Criteria for inclusion were
*  peer-reviewed  published papers evaluating the association  between exposure  to ozone
or particles  and clinically  identifiable human  health effects  (biochemical  and molecu-
lar effects were not included); and
*  papers  that  quantified  any type  of particles:  Total  Suspended  Particles  (TSP),  black
smoke (BS), coefficient of haze (CoH), or any PM.' 0
0 We  used the  approach of Dockery  and others  (1993)  to  convert  air quality expressed  in these metrics  into
PM1O  concentrations.
21Criteria for exclusion were
*  papers that did not present  information  for the variance,  standard error or confidence
intervals of the association estimate;
*  reports based  on small populations  or excessively large  confidence  intervals  or  stan-
dard errors;
*  papers that did not control  for temperature  and seasonal variation over the study time
period;  and
*  papers that did not correct for ozone effects when addressing PM1O  and vice versa.
According  to these  criteria,  126 publications  were selected  for the  statistical analysis  of
ozone and PM1o health effects (the list appears in Cesar and others 2000).
Exposure-Response Functions
Most studies express the health effect (y) as a function of the degree of change  in health
and the measured  change in air pollutant levels (AC).  The  calculation of the corresponding
change  in health impact  (Ay) depends  on the exposure-response  (ER)  functions  from epide-
miological  studies.  The ER-function estimations  may differ from each other in several ways,
for example,  in the use of standard definitions  of health endpoints,  baseline populations  and
the  functional  form of the estimated relationship.  Some  studies assume  linear relationships,
while others use log-linear functions.
The linear relationship  is of the form
y=a+ lBC  (5.1)
The log linear relationship  is of the form:
y = a * e Fc or, equivalently ln(y) = (x + ,-C  (5.2)
Despite  some  statistical  limitations,  results  from  different  studies  were transformed  to
percent  changes  in the health  effect for each  10 units of variation in the pollutant concentra-
tion.
Pooled  Estimates
We  obtained  a single  pooled  estimate  of the health  effects  reported  from the  selected
studies by using a weighted average.  Deciding  on a method to obtain  an average  estimate  is
not an easy task. Estimates  from different  studies could be different because of random varia-
tion and also because  of a true difference coming  from differences  in exposure and suscepti-
bility factors.  To  take into account  heterogeneity  of effects  of reported  studies  we applied  a
random-effects  model  to pool  the  studies  (DerSimionian  and  Laird  1986.)  Random-effect
models  assume  that the true  effect  is  decomposed  into  the mean population  effect and be-
tween-study  variability.  With a random-effects  model the estimate of the average value is the
22weighted  average of the  study estimates  taking into consideration  the sampling error and the
between-study variability.  Note that the within-study variability  is not taken into account and
only the average estimate  is used in the quantification of the health benefits.
Since  the  analysis  applies  to  Mexico  City,  articles  based  on  Mexico  City  population
were  given double the weight of international cases because they are thought to better reflect
the Mexican  reality in  terms of susceptibility and sociodemographic  characteristics.  The po-
tential  influence  of long-term  exposures  on health,  and especially  in the reduction of life ex-
pectancy,  could be  one of the most influential  end points.  This is discussed  in more detail  in
box  5. 1. An example of mortality due to acute exposure to PM1o is presented in box 5.2.
Table  5.1  summarizes  the  ER functions  and  the  background  rates  for health  effects  as
they are used in the present study. The exposure  response coefficients  in the second and third
columns  of the table come  from  the meta-analyses  described  above.  (For some  health end-
points, a meta-analysis  was not possible and the source of the estimate is a single study.)  The
studies used to derive each  coefficient reported in table  5.1 may be  found in Cesar and others
(2000).  In the next two  sections we will include only nonoverlapping  health endpoints to pre-
vent double  counting of the benefits from air pollution reduction.
Box 5.1  Premature  Mortality Due to Long-Term  Exposure  to PM 10
Cross-sectional  studies  and  cohort  studies  have  been  conducted  to  study  the  effect of
long-term  exposure  to  particles  and  premature  mortality.  Cohort  studies  are  preferable to
cross-sectional studies because cohort studies can  control for other factors related  to mor-
tality such  as  smoking  status  or  occupation.  To  date  three  cohort  studies  in the  United
States  have  followed a significant  number of individuals for at least 8 and  up  to  17 years
(Dockery and  others  1993,  Pope  and  others  1995,  Abbey  and  others  1993).  During  the
study  period,  air  pollution  data  were  gathered  from  local  monitoring  stations  to  estimate
average pollution  exposures for individuals within the study. The  1999 U.S.  EPA Report to
Congress  on the Benefits  and  Costs of the  Clean Air Act  1990 to 2010 and  other authors
prefer to  use the Pope and others  (1995)  study, which is based  on extensive evaluation of
confounders,  as  well  as a larger  sample size and  greater  geographic  coverage.  This co-
hort  study  found  a concentration-response  coefficient of  17  percent  for  a 24.5 ug/m3 in-
crease  of PM 25, or a 6.6  percent increase for a 10 pg/iM3 increase of PM 2 5. For compari-
son  with  PM 10 studies,  this  is equivalent to  an  increase in mortality rates of 3.84  percent
for a 10 ,g/m3 increase of PM 10.
23Table  5.1  Best Estimates  of Exposure-Response  Functions for the ZMVM  for the General
Population (unless  stated otherwise)
Percent  Percent change  Background
change per  per 10,ug/m3  rates
10 ppb daily  daily average  (per 100,000
Endpoints  1-h max ozone  PM 1o  persons)  Notes
Hospital admission
Respiratory  3.76  1.39  411
Cardiocerebrovascular  0.98  0.60  403
Congestive heart failure  - 1.22  5.1
Emergency room visits (ERV)
Respiratory  3.17  3.11  3,168
Restricted activity days (RAD)
Total (adults)  - 7.74  646,050




Total (children)'  7.74  646,050  in adults
Work loss days women due to
RAD  in childrenh  - 7.74  332,000
Minor restricted activity days (MRAD)
Total (adults)  2.20  4.92  780,000
Effects in Asthmatic'
Asthma  attacksa  2.45  7.74  12,740
Cough without phlegm (chil-
dren)  - 4.54  21,200
0.  1  * chronic
cough without
Cough with phlegm  (children)  - 3.32  2,120  phlegm
Cough with phlegm & bron-
chodilator usaged  - 10.22  56,174
Some  respiratory symptoms  Same as cough
(children)  0.66  - 21,200  without  phlegm
Lower respiratory symptoms  0.23  - 8,810
Respiratory symptoms
Upper respiratory symptomsd  1.50  4.39  22,400  1
Lower  respiratory symptomsd  2.20  6.85  9,000  1
Wheezed  1.32  - 10,600
Acute bronchitisd  - 11.0  4,400
Morbidity-Chronic Exposure
Chronic  bronchitis, additional
cases  - 3.60  707
Chronic cough,  prevalence
(children)  - 0.30  5,770
Mortality-Chronic Exposure
Totale  - 3.84  b  1
Mortality-Acute Exposure
Total'  0.59  1.01  577.9
lnfant'  - 3.52  3,133
Source:  Cesar and others (2000),  Summary Tables,  11.4.
a. Included in  MRAD  (U.S.  EPA 1999).
b. Estimated with life expectancy and survival probability tables  by 1-year age interval,  see section  111.2.2.
c. ER-functions to be applied to asthmatics in population only (5  percent of population).
d. Included in  RAD  for PM,o (U.S.  EPA 1999).
e.  Originally identified for people age 30+ but applied to all population.
f. Not included in aggregated  benefit estimates because of methodological problems of separating morality asso-
ciated with acute exposure from mortality associated with chronic exposure.
g.  Assumed the same ER-function as RAD  total adults.
h.  WLD in adult women due to RAD  of their children.
1.  Boletin de Informaci6n  Estadistica.  Dafos a la Salud. Secretarla de Salud, Septiembre,  Mexico (1996).
24Box 5.2  Percent Change  in Mortality Due  to Acute Exposure  to PM10
Of all  the toxic effects  attributed to  PM 10, death has  been  the most thoroughly documented.
Death  due  to  the acute effects of air  pollution occurs generally  between  one  and five  days
after the  hazardous  exposure.  Since  the  1950s  studies have  recorded  increased  mortality
associated with  high  levels  of pollution.  This analysis  includes the  major studies  carried  out
in the Americas,  Europe,  Australia and Asia since 1970.
The  figure  below  shows  the  percent  change  in  general  mortality  associated  with  an  in-
crease  in air  pollution.  The  percent  change,  considering  all  the  cases,  establishes  an  in-
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Note:  Percent  change  in general,  nonaccidental  mortality  for  each  10  pg/iM3 increase  in PM 1o. The
numbers represent  the following  studies:  1.  Anderson  and others  1996  (London),  2. Ballester and oth-
ers  1996 (Valencia),  3. Borja-Aburto  and others  1997  (Mexico), 4. Bremner and  others 1999  (London),
5. Dockery  and  others  1992  (St.  Louis),  6. Dockery  and  others  1992  (Tennessee),  7. Gamble  and
Lewis  1996 (Chicago),  8. Gamble and  Lewis 1996 (Utah),  9. Ito and Thurston  1996 (Chicago),  10. Kel-
sall  and  others  1997  (Philadelphia),  11.  Kinney,  Ito,  and  Thurston  1995  (Los Angeles),  12.  Lee  and
Schwartz  1999  (Seoul),  13.  Mazumdar and Sussman  1983  (Pittsburgh),  14.  Moolgavkar and  Luebeck
1996  (Ohio),  15.  Moolgavkar and others  1996  (Philadelphia),  16.  Neas,  Schwartz,  and  Dockery  1999
(Philadelphia),  17.  Ostro  1995  (California),  18.  Ostro  and others  1996  (Santiago),  19.  Pope  and  Kalk-
stein  1996 (Utah),  20.  Pope III  1999  (Ogdem),  21.  Pope,  Hill, and Villegas 1999 (Provo),  22.  Pope, Hill,
and Villegas  1999  (Utah),  23. Samet  and others  1998  (Philadelphia), 24. Schwartz  1994c (Cincinnati),
25.  Schwartz  and  Dockery  1992a  (Philadelphia),  26. Schwartz  and  Dockery  1992b  (Steubenvile),  27.
Schwartz  1993  (Birmingham),  28.  Schwartz  1994b (Detroit),  29.  Schwartz  1994c  (Ohio),  30. Simpson
and  others  1997  (Brisbane),  31.  Spix  and  others  1993  (Erfurt),  32.  Sunyer  and  others  1996  (Barce-
lona),  33. Touloumi  and others  1996  (Athens),  34.  Touloumi,  Samoli, and  Katsouyanni  1996  (Athens),
35 Verhoeff and  others  1996  (Amsterdam),  36. Wordley, Walters,  and  Ayres  1997  (Birmingham),  37.
Zmirou and others  1996 (Lyon),  38. Castillejos and others 2000 (M6xico),  39. Cropper and others  1997
(Delhi), 40.  Pooled estimate.
Pooled Estimate of the Effect of PM 1 0 in Total  Mortality
Mortality  Mean  C195%
Total  1.01  0.83,1.19
25Health  Effects
The morbidity avoided  due to a reduction in exposure  to PM,o and ozone are now calcu-
lated as follows:
I = AY * Yb  ACpopw *  Pop  (5.3)
With:
I  = Impact
AY  = ER-function coefficient (percent change in impact per unit of pollutant)
Yb  = Background health impact rate (impacts/100,000  persons)
ACp,pw  = Population weighted change in exposure  (concentration/person)
Pop  = Population exposed (persons)
Box 5.3 presents  estimates of avoided hospital admissions  for respiratory problems  with
a  10-percent reduction  in annual  average  daily  1-hour  maximum  ozone  concentrations.  The
avoided morbidity impacts are expressed in number of cases.
When quantifying the avoided mortality impacts it is important  to take into account that
the  exposure-response  functions provide  estimates  of premature  mortality rather than  addi-
tional deaths.  The economic valuation of an additional death is quite different from the valua-
tion of only a  limited number of years  of life  lost (YOLL).  Following  ExternE  (1999) we
have  assumed  that  acute  and  chronic  premature  mortality  leads,  on average,  to  0.75  and  5
years  of life lost per case respectively.  The quantification  of the number of YOLL related to
mortality  associated  with  acute  exposure  is  thus  equal  to the  number of premature  deaths
times  the  average  YOLL  (0.75  years).  The  quantification  of the avoided  YOLL  related  to
mortality associated with chronic  exposure  is more complex  as death occurs  later. Therefore,
the age-specific  life expectancy  and death rates are taken into  account.  A more detailed dis-
cussion of the method followed is presented in Cesar and others (2000).
Tables  5.2  and  5.3 present  the  morbidity  health benefits  for the air pollution  reduction
scenarios  discussed in sections 3 and 4. Table 5.4  gives the mortality health benefits  for the
air pollution reduction  scenarios.
Box 5.3  Estimation of Avoided Hospital Admissions for Respiratory Problems
Due  to Ozone  Pollution Improvements  in 2010
*  A 10 percent improvement  of air quality results in a reduction of population
weighted exposure of 0.011357 ppm/person (ppm  relates to annual  average  daily
1-hour max ozone concentration), see section 4.
. The background  rate for this type of hospital admissions is 411  per 100,000 per-
sons per year.
*  The exposure-response relation is 3.76 percent per  10 ppb ozone concentration
change.
So the number of avoided  admissions is: 0.0376/10 change/ppb x 1,000 ppb/ppm
x  0.00411  admissions/person  x 0.011357 ppm/person  x  18,787,934 persons =  3,300
admissions.
26Table  5.2  Reduction  in Morbidity Health Impacts  Due  to Ozone  Pollution Reduction
Scenarios for the ZMVM  in 2010
Scenario
Endpoints  10%  20%  AQSI  AQS2
Hospital admission
Respiratory  3,300  6,600  20,404  22,597
Cardiocerebrovascular  842  1,684  5,207  5,767
Emergency room visits
Respiratory  21,429  42,857  132,501  146,746
Minor restricted activity days
Total (adults)  2,495,805  4,991,610  15,432,494  17,091,616
Effects in asthmatics
Asthma  attacksb  3,330  6,660  20,591  22,805
Some respiratory  symptoms  404  809  2,501  2,770
(children)
Table  5.3 Reduction  in Morbidity Health Effects  Due to PM 10 Pollution Reduction
Scenarios for the ZMVM  In 2010
Scenario
Endpoints  10%  20%  AQS1  AQS2
Hospital admission
Respiratory  688  1,376  1,510  3,221
Cardiocerebrovascular  291  582  638  1,361
Congestive heart failure (elderly)  0.36  0.71  0.78  1.66
Emergency room visits
Respiratory  11,858  23,717  26,029  55,507
Restricted activity days
Total (adults)  4,102,282  8,204,565  9,004,464  19,202,173
Work-loss  days (adults)  998,116  1,996,233  2,190,854  4,672,035
Total (children)  1,630,710  3,261,421  3,579,391  7,633,112
Work-loss days for women  due  428,269  856,537  940,045  2,004,662
to RAD  in children
Minor restricted activity days
Total (adults)  3,148,315  6,296,630  6,910,516  14,736,794
Effects in asthmatics
Cough without phlegm  (children)  1,569  3,139  3,445  7,346
Cough with  phlegm (children)  115  230  252  537
Chronic morbidity
Chronic  bronchitis, new cases  3,063  6,126  6,723  14,337
Chronic cough, prevalence  574  1,148  1,260  2,686
(children)
27Table 5.4 Reduced  Deaths or YOLL Related  to Ozone and PMl 0 Pollution Reduction
Scenarios for the ZMVM  in 2010'
Scenario
Endpoints  10%  20%  AQSI  AQS2
Mortality-acute exposure
Total population-YOLL Ozone  546  1,091  3,374  3,737
Modality-chronic exposure
Total population-YOLL PM10 14,131  28,261  31,016  66,143
a.  3%  discount rate, average YOLL per death are 0.75 and five years for morality associated with
acute and chronic exposures,  respectively.
6. Economic Valuation of Scenarios
Earlier studies suggested that improving air quality in Mexico  City would bring limited
benefits  (Hernandez-Avila  and  others  1995).  These  studies, however,  used a  narrow  defini-
tion of health benefits. Estimates of the effects of air pollution on human health were quanti-
fied  for fewer  endpoints than  in section 5. In addition,  health benefits were valued using  a
very narrow definition of benefits.  Reductions  in premature mortality were valued by the as-
sociated increase in eamings (the human capital approach).  Reductions in illness were valued
using the savings  in medical costs and reductions  in lost work time that result from reducing
illness (the Cost of Illness approach).  In the present study we use a broader definition  of the
value of health benefits:  In addition  to valuing  avoided illness costs and productivity  losses,
we estimate the amount that people are willing to pay to avoid the discomfort associated with
illness  and  the  disutility  associated  with premature  death.  This  section  first  discusses  the
methods  used to value health  benefits in this study.  Next we present the main  results of the
health benefit analysis  and the economic  benefits of a reduction in the number of contingen-
cies experienced."
Economic Valuation of Premature  Mortality and Morbidity
Economists value avoided premature mortality by the amount that people  are willing to
pay to reduce their risk of dying (Hernandez-Avila  and others  1995). Ideally,  "willingness  to
pay"  (WTP) should  capture the loss in satisfaction-from  consumption, leisure  time, interac-
tion with friends and family-that occurs when life is shortened.'2 It should, in particular, ex-
ceed  the  monetary  value  of the  consumption  (or  income)  lost when  a person  dies  prema-
turely.  In studies conducted in the United  States (Viscusi  1993)  estimates of WTP to reduce
risk of death suggest that WTP  is between 8 and 20 times as large as the corresponding  gain
in earnings from living longer.  (The methods used to estimate WTP for reduced risk of death
are  discussed below.)  Ideally,  changes  in premature  mortality  should be valued using WTP.
The  value of earnings  lost when a person  dies prematurely  (the Human  Capital  measure of
" A  more detailed  discussion  of the methodology,  the assumptions and  the results  is presented  in Cesar  and
others (2000).
12 Typically,  WTP to reduce risk of death is  expressed in terms  of the Value  of Statistical  Life (VSL).  If each
of 10,000 people  are willing to  pay $100  to reduce  their risk of dying by  I in  10,000, they  are together  WTP
$1,000,000 for risk reductions  that sum to one statistical  life. The $1,000,000  is termed the Value of a Statistical
Life.
28the value of reduced risk of death) will,  in general,  understate the economic  value of reduced
risk of death (Freeman  1993).
Avoided  morbidity is also valued by the amount a person will pay to avoid  a particular
illness.  For minor illnesses  (such  as respiratory  infections)  the  correct  valuation  concept  is
what  an individual  would pay to  avoid  the  illness with  certainty.'3 This  should  capture  the
value of the pain and suffering avoided,  as well as the value of time lost due to  illness (both
leisure and work time)  and the costs of medical treatment.  In cases where  some of these costs
are not bome by the individual,  and are therefore  not reflected  in his WTP,  the value of the
avoided costs must be added to WTP to measure the social benefits of reduced morbidity.  It
is often  the case  that the costs of medical  treatment  (hereafter referred  to  as COI) and  time
lost from  work (Productivity  Loss)  are not borne  by the sick person.  We  therefore measure
the value of avoided mortality by WTP to avoid lost leisure time and the discomfort associ-
ated with illness,  but add to this the value of lost productivity and the costs of medical treat-
ment. As in the case of mortality,  it can be argued that the avoided value of lost productivity
and medical costs  alone will  understate  the  economic  value of reduced  morbidity  (Freeman
1993).
Estimates of WTP to reduce risk of death and estimates of WTP to avoid illness unfortu-
nately do not exist for Mexico.  It is therefore  necessary  to transfer to Mexico estimates  from
countries  where  WTP  studies  have  been conducted.  When  extrapolating  estimates  of WTP
from one country to another,  adjustments must be made for the effect of income on WTP. In
general, WTP (both for mortality and for morbidity) should increase with income. In transfer-
ring estimates from country A to Mexico the formula used is
WTPMEXICO = WTPA  [IncomeMExlco/IncomeA]
where  c represents  the  income  elasticity  of WTP-the  percentage  change  in WTP  corre-
sponding to a one percent change in income.
It should  be acknowledged  that there  is considerable  uncertainty regarding  estimates of
the  income  elasticity of WTP,  especially  for mortality,  as well  as  uncertainty regarding  the
estimates of WTP themselves.  We handle  this uncertainty  in two  ways. First, we use two es-
timates of the income elasticity of WTP-1.0, and 0.4. Holding WTPA constant,  the 0.4 elas-
ticity results in a larger WTP  estimate  for Mexico than the  1.0 elasticity.  Indeed,  when WTP
estimates  from  the United  States  are  transferred  to Mexico  using Purchasing-Power-Parity-
adjusted income, an income  elasticity of 0.4 implies  a WTP for Mexico that is about the size
of WTP in the US.  We therefore view WTP estimates based on an income elasticity of 0.4 as
upper bound estimates,  and estimates based on an income elasticity of 1.0 as central case  es-
timates.
Second,  to handle uncertainty  about the size of WTP,  especially WTP  for reduced  mor-
tality, we also present conservative,  lower bound estimates  of the value of mortality and mor-
bidity.  Specifically,  we  measure the value of avoided premature  mortality using the Human
Capital/foregone  eamings  approach,  as  well  as by transferring  estimates  of WTP  to reduce
13  In  the  case of rarer  events,  such  as  heart  attack  or stroke,  the correct  valuation  concept  is  what  a person
would pay to reduce his risk of the illness occurring.
29risk of death from other OECD countries  to Mexico.  In the case of morbidity we present  es-
timates  of  avoided  illness  costs  and  productivity  losses  alone  (i.e.,  without  WTP)  as
conservative,  lower bound estimates of the benefits of reduced morbidity.
To  summarize,  3 sets of benefit  estimates  are provided for each  of the four  air quality
scenarios analyzed.  (See Table  6.1.) Health Benefit Estimate  1, the most comprehensive,  in-
cludes  WTP  to  avoid illness,  as well  as  avoided  illness  costs  (COI)  and  reduced  losses  in
productivity,  in  valuing  reduced  morbidity.  Avoided  premature  mortality  is  valued  using
WTP.  Health Benefit  Estimate  2  includes  the  same comprehensive  measure  of the value  of
reduced morbidity,  but values avoided premature  mortality using  foregone earnings,  a lower
bound  to  WTP.  Health  Benefit  Estimate  3, the  most conservative,  values  morbidity  using
COI  and  productivity  measures  alone  and  premature  mortality  using  foregone  earnings.
Health Benefit  Estimates  1 and  2 vary  depending  on the  income  elasticity  used to  transfer
WTP estimates for morbidity and mortality from other countries to Mexico.
For reasons  described more fully below, we view Health Benefit Estimate 1, with an
income elasticity of 1.0 used  for benefits transfer,  as  a Central  Estimate of the value  of
health benefits. Health Benefit Estimate  1, using an income elasticity of 1.0,  is viewed as
a High  Estimate  and Health Benefit  Estimate  3 as  a Low  Estimate.  We  interpret  Health
Benefit Estimate 1, using an income  elasticity of 1.0 for benefits transfer,  as  a "Central  Esti-
mate" of the health benefits of pollution reduction.  This is motivated by the belief that the es-
timates of WTP  for reduced  morbidity used  in the  analysis  are  more reliable  (and certainly
less controversial) than the estimates of WTP for reduced risk of death.  It is also the case that
WTP for reduction  in risk of death is based on small risk changes.  Applying a marginal WTP
estimate to the large risk changes  in AQS 1 and AQS2  may yield implausibly large estimates
of WTP. Health Benefit Estimate  3, which uses a lower bound estimate for morbidity (= Pro-
ductivity  Loss  +  COI)  and  mortality  (Human  Capital  approach),  is  a  conservative,  lower
bound estimate to benefits.
Table  6.1  Overview of Health Benefit Estimates  Presented  in the Study
Income elasticity of WTP
Components of Health Benefits  1.0
1. Health benefit estimate 1 including morbidity  High estimate
(Prod.  Loss + COI +WTP)  and WTP for mortality
2. Health benefit estimate 2 including morbidity  Central estimate
(Prod.  Loss + COI +WTP)  and human  capital
losses for mortality
3. Health benefit estimate 3 including morbidity  Low estimate
(Prod.  Loss + COI) and human capital losses for
mortality
The following sections explain in more detail how productivity losses, COI, human capi-
tal losses  and WTP are measured. For a more detailed discussion of these methods  see Cesar
and others (2000).
30Loss of  Productivity
Loss of productivity  (also  referred  to as the  "change  in productivity"  method  or "effect
on production")  is a valuation method that computes  the loss in output due to illness or some
other event. The loss of productivity method is applied in two situations.
First,  environment-induced  health  effects  reduce production.  Foregone  income  as  a  re-
sult of illness,  which is assumed to be evenly distributed over time, is valued by using the av-
erage wages  in the formal  and informal  sectors (see  Cesar and  others 2000 for a further dis-
cussion).  Assuming  an  annual  increase  of 2.45  percent  the  formal  and  informal  daily wage
level  in  2010  are  US$ 24.8  and US$  10.3,  respectively  (2010 values  in  1999  prices).
14 For
those air pollution-related health effects where  we are not able to identify the age of the peo-
ple  affected  we use the  population-weighted  wages  for the  whole  ZMVM population.  This
leads to  an average  daily wage of US$  6.49 (2010 values in  1999 prices).  Using total popula-
tion-weighted  wages  to estimate  morbidity  damage  for  specific  age  groups  in  the  ZMVM
would lead to an  underestimation of the  damages  if only adults  or children  are  affected and
an overestimation  of the damages  if only the  elderly are affected.  15  For effects  in the elderly
we  assume  no  economic  losses  occur.  For effects  in  adults  and  children  we  use  an  adult
population-weighted  wage in of US$ 9.52 (2010 values in  1999 prices). The assumed number
of "days lost" due  to air pollution is presented in table 6.2
14  In  the absence of data on the expected wage growth  in Mexico we have used the growth in GNP per capita as
a proxy by deducting  the population  growth rate (1 percent)  from the expected growth in GNP  (3.7 percent).
15 Effects resulting in loss  of time for children  leads  to productivity losses  in adults resulting  from  care for the
children.
3]Table  6.2 Days Lost Per Case  in Mexico City for the General  Population
(unless  stated otherwise)
Endpoints  Days lost'  Source
Hospital admission
Respiratory  8  ExternE  (1999, 2000)
Cardiocerebrovascular  45  ExternE  (1999,  2000)
Congestive heart failure (elderly)  7  ExternE  (1999,  2000)
Emergency room visits
Respiratory  5  ExternE  (1999, 2000)
Restricted activity days
Total (adults and children)  ob
Work-loss day  I
Minor restricted activity days
Total (adults)  0  Assumed
Effects in asthmatics
Asthma  attacks  1  ExtemE (1999,  2000)
Cough without phlegm  (children)  1  Assumed
Cough with phlegm (children)  1  Assumed
Some respiratory symptoms  (children)  1  Assumed
Chronic morbidity
Chronic bronchitis, additional cases  7  Extrapolated from  ERISCAC
Chronic cough, prevalence (children)  7  Extrapolated from  ERISCAC
a. Including recovery days at home.
b. The loss-of-productivity part is accounted for by the work-loss-day part of RAD.
c. See Cesar and others (2000).
Second, loss  of productivity occurs  during environmental  contingencies  (ECs) or alerts.
As discussed in section 2.2  these alerts lead to temporary  closures  in production infrastruc-
ture to avoid further air pollution.  Here the loss of productivity is measured by estimating the
difference in gross national product  (GNP) with and without  an environmental  alerts.  A dis-
tinction has been made between production losses in the industry and the transport sectors.
Cost of Illness
The cost of illness for the different  morbidity endpoints  is quantified  in terms of direct
costs  for treatment of an illness. These  costs are dependent on the social  security system.  In
Mexico  the most  common health  systems are  the public  health  insurance  system for  unin-
sured people (Poblacion  Abierta), the public health system for low-income  employed people
(IMSS),  and  the  private  health  insurance  system  (Privado). Hemandez-Avila  and  others
(1995)  conducted a COI study for Mexico  by including the costs  of consultations,  laboratory
tests,  and  medication.  The inflation-corrected  numbers  they  obtained  are presented  in table
6.3.
32Table  6.3 Cost of Illness Per  Case  in Mexico for the General  Population (unless stated oth-
erwise)
(costs  in US$,  2010 values in 1999 prices)
Cost of Illnessa
Public
Endpoints  services  IMSS  Private  Others  Averageb
Hospital admission
Respiratory  939  1,252  3,131  1,565  1,870
CardiocerebrovascularC  2,818  3,757  9,392  4,696  5,611
Congestive heart failure (elderly)d  939  1,252  3,131  1,565  1,870
Emergency room visits
Respiratory  211  50  83  50  91
Restricted activity dayse  10  10  10  10  10
Minor restricted activity days
Total (adults)  ng  ng  ng  ng  ng
Effects  in asthmatics
Asthma attacks  271  199  572  199  337
Cough  without phlegm  (children)  ng  ng  ng  ng  ng
Cough with phlegm (children)  ng  ng  ng  ng  ng
Some respiratory symptoms (children)  ng  ng  ng  ng  ng
Respiratory symptoms  10  10  10  10  10
Chronic morbidity
Chronic bronchitis  153  168  326  168  218
Chronic cough (children)  169  136  279  136  190
ng = Assumed negligible.
a.  From  Hernandez-Avila and  others (1995).
b. Based on National  Health Survey,  ENSA  111994,  18.6%  public insurance,  31.9% IMSS, 33.3%
private insurance,  and  16.2% other.
c. Assumed three times  respiratory hospital admissions
d. Assumed  same as respiratory hospital admissions.
e. Assumed  same as respiratory symptoms. Only 46% of the work-loss-day portion of restricted
activity days are valued with a COI  component (Krupnick 2000).
Human Capital Loss
The  human  capital  approach  is  used  for  valuing  the  lost productivity  associated  with
mortality.  This approach assumes  that the value of a person is equal to what he or she would
have produced,  that is, the  discounted present  value of a person's  expected  future  earnings.
The  value of lost  productivity  may also  include  nonmarket  productivity,  for  example,  the
value of household production.  Other dimensions of illness and death, such as pain, suffering,
and  loss  of leisure  are  excluded.  The  difference  between  the  productivity  loss  and  human
capital  is that the former accounts for the  short-term  production  losses caused  by morbidity,
while the latter focuses on the production  losses in the long term caused by increased mortal-
33ity. Therefore  discounting is applied  only to human capital  loss. Following  Pearce  and Ulph
(1995) a social discount rate of 3 percent has been used.'6
Willingness to Pay
As noted above, economists consider the appropriate value of avoided premature mortal-
ity to be what  an individual  would pay to reduce  his  risk of death.  This should  reflect  the
value of foregone consumption and leisure time and the loss of contact with loved ones. WTP
can be estimated using the contingent valuation method (CVM) and hedonic pricing.
CVM estimates  the WTP or willingness  to accept (WTA) a change in the quantity and/or
quality  of a  good by  using  survey  techniques  (Mitchell  and  Carson  1989  and Hoevenagel
1994).  In the questionnaire  a hypothetical change is described and the respondent is asked di-
rectly  for his WTP or WTA  this change.  The main  values derived  through the  CVM  in this
study are for health impacts such as asthma attacks and premature death.
Hedonic pricing  estimates the WTP/WTA through  (i) the difference in the value of the
same  property in different areas with different environmental  risks (property  value differen-
tial);  or (ii)  the wage differential  people  are willing to pay (or accept) for a decrease (or in-
crease)  in risk of death related to a job.
In this study we focus on the WTP estimated  through CVM and wage differential  stud-
ies.  Because  CVM  is  a costly  and complex method,  studies  have been conducted  in only a
limited number of countries  for a limited number of environmental  goods and services.  In the
United  States  and Europe  numerous  CVM studies  have  been  conducted  on the WTP  to  re-
duce the risk of mortality and morbidity impacts.  Wage differential studies are also numerous
in these countries.  WTP/WTA  estimates,  based on both CVM and wage  differential  studies,
are  not  available  for Mexico.  Therefore,  we  estimate  the  WTP  for  risk  reduction  through
"benefit transfer" of WTP studies perfortned outside Mexico.
Benefit transfer is an application of monetary values from a particular valuation  study in
one  area to a policy decision  setting in another  geographic  area (Navrud  1999).  When trans-
ferring  values  it is  important to know  when  data from other studies  can  be used and under
what conditions.  The value that people attach to avoided health risks depends on the type and
magnitude of risk (low probability, high impact),  the extent to which the risk is experienced
voluntarily,  on cultural settings,  income, and the futurity of the risk. The most important  fac-
tors for applying benefit transfer  in this study are  the level  of real per capita income,  repre-
sented  by purchasing  power  parity  (PPP)  per  capita  income,  and  the  income  elasticity  of
WTP  (6).17  For reasons  explained  above we assume a best estimate  for the income elasticity
of 1.0.18
16 A more extensive  discussion on the discounting  can be found in Cesar and others (2000).
" It seems plausible that risk preferences  might also  change with the status of development.  However,  we have
not included this difference in risk aversion between countries in our benefit transfer due to lack of data.
js A more elaborate  discussion on WTP and benefit transfer is presented in Cesar and others (2000).
34The  original  values  of WTP  for the  morbidity  endpoints  are based  on  report from  the
Centre  for  Social  and Economic  Research  on the  Global  Environment  (Pearce  and  others
1999), U.S.  EPA (1999), and ExternE (1999).i9  Table 6.4  shows the values derived for Mex-
ico using different income elasticities.
Table  6.4  WTP  Estimates for Morbidity Impacts  Obtained with CVM
(in US$, 2010 values in 1999 prices)
Income elasticity
Health endpoint  0  0.4  1
Hospital admission
Respiratory  550  330  153
Cardiocerebrovascular  550  330  153
Congestive heart failure (elderly)  550  330  153
Emergency room visits
Respiratory  284  170  79
Restricted activity days
Totala,b  49  35  21
Minor restricted activity daysc
Total (adults)  49  35  21
Effects in asthmatics
Asthma attacks  52  31  15
Cough  without phlegm (children)c  49  35  21
Cough  with phlegm (children)c  49  35  21
Some  respiratory symptoms  (children)c  49  35  21
Chronic morbidity
Chronic bronchitis,  new cases  422,991  253,899  118,074
Chronic cough, prevalence  (children)  287  199  116
a. All RADs  are valued using WTP. The work-loss days, a subset of RADs,  are not valued sepa-
rately to prevent double counting.
b.  We value restricted activity days (RADs)  as a cough episode and thus equal to a minor re-
stricted activity day.  This underestimates  the WTP for RADs.  However,  Pearce and others  (1999)
found the value of a bed day,  which might be seen as an overestimate of the  RAD as not all
RADs are bed days, to be only 30%  higher than WTP to avoid cough.
c. Following  ExternE (1999)  we value most cases of effects in  asthmatics, cases of respiratory
symptoms,  and minor restricted activity days (MRADs)  as a cough case (episode).  For MRADs
this give the same value as used by U.S.  EPA (1999).
In estimating the WTP for premature mortality it is important to realize  that the number
of life-years  lost due to acute and chronic exposure  to air pollution is limited. Because we in-
tend  to  value  only  the  reduction  in the  number  of life-years  lost,  the  "years  of life  lost"
(YOLL)  approach  has been applied.2 0 The YOLL  approach  is particularly recommended  for
deaths  arising from  exposure to air pollution.  The value will  depend on a number of factors,
such as how long it takes  for the exposure to result in an illness and eventually  death. In this
19  See Cesar and others (2000) for a more detailed discussion
20  An alternative  for  the YOLL  approach  is the "value of a statistical life"  (VSL)  approach.  A  comparison  of
the two approaches is provided in the Cesar and others (2000).
35study, the YOLL approach  is used both  in cases where the  hazard has  a significant latency
period before  impact (mortality  associated with chronic  exposure), and  cases where the  im-
pact takes place within a short period of time  (mortality associated with acute exposure).  In
estimating the values of mortality arising from chronic  exposure to particulate  matter we as-
sume that latency and mortality risks are  spread out evenly over a period of 15 years and the
life time reduction  is 5 years  on average  (ExternE  1999).  For mortality associated with acute
exposure in the general population we assume no latency and the average life time reduction
to be  0.75  years (ExternE  1999).  The resulting  "value of life-year"  lost  (VOLY)  based  on
benefit transfer using the PPP approach is reproduced  in table 6.5.
Table  6.5  Value of Life Year (VOLY)
(in  US$,  (2010 values in 1999 prices, 3 percent discount rate) a
VOLY mortality-acute  exposure  VOLY mortality-chronic exposure
Male  Female  Male  Female
Income elasticity = 0  184,750  179,776  140,611  138,308
Income elasticity = 0.4  131,961  128,409  100,434  98,789
Income elasticity = 1.0  79,660  77,515  60,628  59,635
a. Using a VSL of 4.28, 3.06, and  1.85 million US$ (2010 values in 1999 prices) after benefit
transfer of the European  estimate of VSL of 3.36 million  US$ (1999 values in 1999 prices) with
income  elasticity 0, 0.4 and 1, respectively.
b. Differences  in values for males  and females arise from unequal distributions of survival prob-
abilities and  life expectancy.
Results
This section  presents  the main results  of the  economic  valuation of the benefits  of im-
proving  air quality in Mexico City.  A distinction is made between  economic  health benefits
for the air pollution reduction  scenarios presented in section  4 and the benefits  arising from
the reduction  in environmental  contingencies.  Both categories of effects  are then aggregated
and summarized.
Economic Health Benefits
As explained in earlier sections health-related benefits consist of effects resulting from
reducing acute morbidity, mortality associated with acute exposure,  chronic morbidity and
mortality associated with chronic exposure. For the first three categories a straightforward
procedure  is followed by multiplying the physical health impacts (see section 5) by the mone-
tary values for each unit of health impact (see previous section).  The procedure to assess the
damages from mortality associated with chronic exposure-combining  information on life
expectancy,  age dependent mortality rates, and VOLYs-is more complicated.
36Figure 6.1  presents the configuration of the health-related benefits of a reduction  in air
pollution. The productivity losses, the cost of illness,  and the willing to pay are included in
the estimated morbidity benefits.  In the mortality benefit estimates  either the human capital
benefits or the WTP are included.21
Tables  6.6 to 6.9  present the results for WTP estimates derived by benefit-transfer  with
income  elasticities of 0.4 and 1.0.  The results show that the main health damages  are caused
by WTP for a reduction of health impacts.  For PMIo, the economic  value of preventing pre-
mature  death  dominates  the  overall  outcome. A  summary of the  damages  including and ex-
cluding WTP benefits are presented in table 6.10.
Figure 6.1  Health-Related  Benefits of Reduction of Air Pollution
Loss of Productivity  Acute  & chronic
+  morbidity
Cost of Illness
+  J  Health-related
Willingness to  Pay  Benefits
Human  Capital Loss  Acute & chronic
or  mortality
Willingness to  Pay  motly
21  In  the  literature  used  here,  only studies that  specifically  differentiated  between  the costs  categories  (COI,
productivity loss, and WTP) were considered.
37Table 6.6  Health  Benefits of Ozone  Air Pollution Reduction  in the ZMVM
(in million US$ per year a  for income elasticity 0.4,  2010 values in 1999 prices)
Scenario
Endpoints  10%  20%  AQSI  AQS2
Morbidity impacts (Prod.  Loss + COI + WTP)
Hospital admission
Respiratory  7.43  14.86  45.95  50.90
Cardiocerebrovascular  5.25  10.50  32.45  35.94
Emergency room visits
Respiratory  6.30  12.60  38.95  43.14
Minor Restricted activity days
Total (adults)  86.49  172.98  534.79  592.28
Effects in asthmatics
Some respiratory symptoms  (children)  0.02  0.04  0.11  0.12
Lower respiratory  symptoms  0.01  0.02  0.06  0.06
Respiratory symptoms
Upper respiratory symptoms  3.67  7.34  22.69  25.13
Lower respiratory symptoms  2.14  4.28  13.22  14.64
Wheeze  1.23  2.46  7.60  8.41
Morbidity impacts (Prod.  Loss + COI)
Hospital admission
Respiratory  6.34  12.69  39.22  43.44
Cardiocerebrovascular  4.97  9.94  30.74  34.04
Emergency room  visits
Respiratory  2.65  5.29  16.37  18.13
Effects in asthmatics
Some respiratory symptoms  (children)  0.00  0.01  0.02  0.03
Lower respiratory symptoms  0.00  0.00  0.01  0.01
Respiratory symptoms
Upper respiratory symptoms  1.19  2.37  7.33  8.12
Lower respiratory symptoms  0.69  1.38  4.27  4.73
Wheeze  0.19  0.39  1.20  1.33
Mortality impacts-WTP
Mortality-acute exposure (total)  70.07  140.13  433.25  479.83
Mortality impacts-Human  capital losses
Mortality-acute exposure  (total)  1.67  3.34  10.33  11.44
Total - Morbidity (Prod.  Loss+ COI  +WTP) and  183  365  1129  1250
WTP for mortality
Total - Morbidity (Prod.  Loss+ COI  +WTP) and  114  228  706  782
human  capital losses mortality
Total - Morbidity (Prod.  Loss + COI) and  18  35  109  121
human  capital losses mortality
a. Discount rate 3%.
38Table  6.7  Health  Benefits of Ozone  Air Pollution Reduction in the ZMVM
(in million US$  per year a for income elasticity 1.0,  2010 values in 1999 prices)
Scenario
Endpoints  10%  20%  AQS1  AQS2
Morbidity impacts (Prod.  Loss + COI + WTP)
Hospital admission
Respiratory  6.85  13.70  42.35  46.91
Cardiocerebrovascular  5.10  10.20  31.53  34.93
Emergency room  visits
Respiratory  4.35  8.69  26.87  29.76
Minor  Restricted activity days
Total (adults)  55.21  104.42  322.83  357.54
Effects in asthmatics
Some respiratory symptoms  (children)  0.01  0.02  0.08  0.08
Lower respiratory symptoms  0.01  0.01  0.04  0.04
Respiratory symptoms
Upper respiratory symptoms  2.68  5.37  16.60  18.39
Lower respiratory symptoms  1.56  3.13  9.67  10.71
Wheeze  0.82  1.64  5.06  5.60
Morbidity impacts (Prod.  Loss + COI)
Hospital admission
Respiratory  6.34  12.69  39.22  43.44
Cardiocerebrovascular  4.97  9.94  30.74  34.04
Emergency room  visits
Respiratory  2.65  5.29  16.37  18.13
Effects in asthmatics
Some respiratory symptoms  (children)  0.00  0.01  0.02  0.03
Lower respiratory symptoms  0.00  0.00  0.01  0.01
Respiratory symptoms
Upper respiratory symptoms  1.19  2.37  7.33  8.12
Lower respiratory symptoms  0.69  1.38  4.27  4.73
Wheeze  0.19  0.39  1.20  1.33
Mortality impacts-WTP
Mortality-acute  exposure (total)  42.30  84.59  261.53  289.65
Mortality impacts-Human  capital losses
Mortality-acute  exposure (total)  1.67  3.34  10.33  11.44
Total - Morbidity  (Prod.  Loss+ COI +WTP)  and  116  232  717  794
WTP for mortality
Total - Morbidity (Prod.  Loss+  COI +WTP) and  75  151  465  515
human  capital losses mortality
Total - Morbidity (Prod.  Loss + CO)  and  18  35  109  121
human capital losses mortality
a. Discount rate 3%.
39Table  6.8  Health Benefits of PM,0 Air Pollution Reduction  in the ZMVM
(in million US$ per yeara for income elasticity 0.4, 2010 values in 1999 prices)
Scenarios
Endpoints  10%  20%  AQS1  AQS2
Morbidity Impacts  (Prod.  Loss +  COI +  WTP)
Hospital admission
Respiratory  1.55  3.10  3.40  7.25
Cardiocerebrovascular  1.81  3.63  3.98  8.48
Congestive  heart failure (elderly)  0.00  0.00  0.00  0.00
Emergency room visits
Respiratory  3.49  6.97  7.65  16.32
Restricted activity days
Total (adults)  161.10  322.20  353.62  754.09
Work-loss days (adults)  14.32  28.63  31.42  67.01
Total (children)  64.04  128.08  140.57  299.76
Work-loss days (working women due to RAD in chil-  6.14  12.28  13.48  28.75
dren)
Minor restricted activity days
Total (adults)  109.10  218.20  239.47  510.68
Effects in asthmatics
Cough without phlegm (children)  0.07  0.14  0.15  0.32
Cough with  phlegm (children)  0.01  0.01  0.01  0.02
Chronic morbidity
Chronic bronchitis, new cases  778.48  1,556.96  1,708.75  3,643.94
Chronic cough, prevalence (children)  0.26  0.52  0.57  1.22
Morbidity impacts (Prod.  Loss + COI)
Hospital admission
Respiratory  1.32  2.65  2.90  6.19
Cardiocerebrovascular  1.72  3.43  3.77  8.04
Congestive heart failure (elderly)  0.00  0.00  0.00  0.00
Emergency room visits
Respiratory  1.46  2.93  3.22  6.86
Restricted activity days
Total (adults)  18.94  37.89  41.58  88.67
Work-loss  days (adults)  14.32  28.63  31.42  67.01
Total (children)  7.53  15.06  16.53  35.25
Work-loss days (working women due to RAD  in chil-  6.14  12.28  13.48  28.75
dren)
Minor restricted activity days
Total (adults)  0.00  0.00  0.00  0.00
Effects in asthmatics
Cough without phlegm (children)  0.01  0.03  0.03  0.07
Cough with phlegm (children)  0.00  0.00  0.00  0.01
Chronic morbidity
Chronic bronchitis,  new cases  0.81  1.61  1.77  3.77
Chronic cough, prevalence (children)  0.15  0.29  0.32  0.69
Mortality impacts-WTP
Mortality (Acute exposure) - Infant  - - - -
Mortality (Chronic exposure) - Total  1,408.53  2,817.07  3,091.71  6,593.13
Mortality impacts - Human  capital losses
Mortality (Acute  exposure) - Infant  - - - -
Mortality  (Chronic exposure) - Total  43.28  86.55  94.99  202.57
Total - Morbidity (Prod. Loss+ COI +WTP)  and WTP for  2,549  5,098  5,595  11,931
mortality
Total - Morbidity (Prod. Loss+ COI +WTP) and human  1,184  2,367  2,598  5,540
capital losses mortality
Total - Morbidity (Prod. Loss +  COI) and human capital  96  191  210  448
losses mortality
a. Discount rate 3%.
40Table  6.9  Health  Benefits of PM, 0 Air pollution Reduction  in the ZMVM
(in million US$ per yeara for income elasticity 1.0, 2010 values in  1999 prices)
Scenarios
Endpoints  10%  20%  AQSI  AQS2
Morbidity impacts(Prod.  Loss + COI +  WTP)
Hospital admission
Respiratory  1.43  2.86  3.13  6.69
Cardiocerebrovascular  1.76  3.52  3.87  8.24
Congestive heart failure (elderly)  0.00  0.00  0.00  0.00
Emergency room  visits
Respiratory  2.40  4.81  5.28  11.26
Restricted activity days
Total (adults)  104.76  209.52  229.94  490.36
Work-loss days (adults)  14.32  28.63  31.42  67.01
Total  (children)  41.64  83.29  91.41  194.92
Work-loss days (working women  due to  RAD in  6.14  12.28  13.48  28.75
children)
Minor restricted activity days
Total (adults)  65.86  131.72  144.56  308.28
Effects in asthmatics
Cough without phlegm  (children)  0.05  0.10  0.10  0.22
Cough with  phlegm  (children)  0.00  0.01  0.01  0.02
Chronic morbidity
Chronic  bronchitis, new cases  362.46  724.92  795.59  1,696.61
Chronic cough, prevalence (children)  0.21  0.43  0.47  1.00
Morbidity impacts (Prod.  Loss + COI)
Hospital admission
Respiratory  1.32  2.65  2.90  6.19
Cardiocerebrovascular  1.72  3.43  3.77  8.04
Congestive  heart failure (elderly)  0.00  0.00  0.00  0.00
Emergency room visits
Respiratory  1.46  2.93  3.22  6.86
Restricted activity days
Total (adults)  18.94  37.89  41.58  88.67
Work-loss days (adults)  14.32  28.63  31.42  67.01
Total (children)  7.53  15.06  16.53  35.25
Work-loss  days (working  women due to RAD in  6.14  12.28  13.48  28.75
children)
Minor restricted activity days
Total  (adults)  0.00  0.00  0.00  0.00
Effects in asthmatics
Cough without phlegm  (children)  0.01  0.03  0.03  0.07
Cough with  phlegm  (children)  0.00  0.00  0.00  0.01
Chronic  morbidity
Chronic  bronchitis, new cases  0.81  1.61  1.77  3.77
Chronic  cough, prevalence (children)  0.15  0.29  0.32  0.69
Mortality impacts-WTP
Mortality (Acute  exposure) - Infant  - - - -
Mortality (Chronic  exposure) - Total  850.28  1,700.55  1,866.35  3,980.02
Mortality impacts - Human  capital losses
Mortality (Acute exposure) - Infant  - - - -
Mortality (Chronic  exposure) - Total  43.28  86.55  94.99  202.57
Total - Morbidity (Prod. Loss+  COI +WTP) and  1,451  2,903  3,186  6,793
WTP for mortality
Total - Morbidity (Prod. Loss+  COI +WTP) and  hu-  644  1,289  1,414  3,016
man capital losses mortality
Total - Morbidity (Prod. Loss +  COI) and  human  96  191  210  448
capital losses  mortality
a.  Discount rate 3%.
41Table  6.10 Summary  Health  Benefits Due to Ozone  and PM 10 Air Pollution Reduction
(in million  US$  per yeara  2010 values  in 1999 prices, 3 percent discount rate)
Scenario
10%  20%  AQS1  AQS2
Income elasticity  1.0  0.4  1.0  0.4  1.0  0.4  1.0  0.4
Ozone  benefits
Total - Morbidity (Prod.  Loss+  COI  +WTP)  116  183  232  365  717  1129  794  1,250
and WTP for mortality
Total - Morbidity (Prod.  Loss+  COI  +WTP)  75  114  151  228  465  706  515  782
and  human capital losses mortality
Total - Morbidity (Prod.  Loss + COI)  18  18  35  35  109  109  121  121
and human capital losses mortality
PM 10 benefits
Total - Morbidity (Prod.  Loss+ COI  +WTP)  1,451  2,549  2,903 5,098  3,186  5,595  6,793  11,931
and WTP for mortality
Total - Morbidity  (Prod.  Loss+ COI  +WTP)  644  1,184  1,289 2,367  1,414 2,598  3,016  5,540
and human capital losses mortality
Total - Morbidity (Prod.  Loss + COI)  96  96  191  191  210  210  448  448
and human capital losses mortality
Environmental Contingencies
The  economic  effects  of ECs in the ZMVM industry sector have been explored through
an  analysis  of value  added  losses  in affected  industries.  Using  1994  data,  value  added has
been estimated here to decrease  39 percent during one day of PM1o contingency and 42 per-
cent in an ozone contingency.22 The costs of a one-day contingency  for PMjo are lower than
for ozone  as fewer industries are involved  in PMjo (the service  sector is left out in PM1O,  but
included in ozone).
As mentioned  in the earlier  sections environmental  contingencies  (ECs) have  two main
cost components:  production losses in industry and transportation.  Productivity losses  in the
transport  sector  are  much less straightforward  to  estimate,  and the lack of data proved  to be
more severe in the transport sector. Given these constraints we focussed solely on production
losses in industry.  Knowing the value of production, the value added,  and labor costs per day
(percent  participation  in the total  costs) allowed  us to calculate  the costs  of production in a
normal  situation  (without  environmental  contingency).  From the  normal  situation  scenario,
the costs of ECs  can be derived  considering  a decline  of 33  percent  of production per day
(see table 6.1 1).23
22 This is  larger than the average  decrease of production of 33 percent for all industries  combined,  as explained
in detail in  Cesar and  others (2000).  The discrepancy  stems from the fact that most workers go to work  and get
paid even  on days  when the production stops partially.  The result is a higher cost of production per unit of prod-
uct.
For a more detailed analysis, see Cesar and others  (2000).
42Table  6.11  Value  Added Losses to ZMVM  Industry during PM 10 and Ozone  Contingencies
(value added  per day in thousands US$  1995 values, 1 US$=9.28  Mex. Peso)
Percent growth  Percent growth
in PM 1O  contin-  in ozone  VA  loss in  VA loss in
gency  contingency  PM10 Ozone
Industry subsectors  (percent)  (percent)  contingency  contingency
Nonmetallic minerals extraction  -42  -42  17.45  17.92
Food, beverages,  and tobacco  -41  -41  259.01  392.08
Textiles and leather industry  -43  -43  68.61  99.89
Wood and wood products  -45  -45  7.86  5.10
Paper industry and printing  -46  -47  40.24  123.16
Chemical industries  -43  -43  215.15  247.84
Nonmetallic minerals industries  -38  -39  282.05  173.06
(no oil)
Basic Metallic industry  -57  -58  70.89  45.09
Metallic products  -48  -47  236.40  276.49
Other manufacturing  -41  -43  16.20  0.99
Services  - -39  - 2.36
Electricity generation  -22  -22  -7.26  -7.00
TOTAL  -39  -42  1,306.57  1,376.94
Source: d= datgen.  Emissions  Inventory 2000;  i= INEGI . Instituto Nacional de Estadistica,  Geo-
grafia e Informatica,  Censo Industrial. Mexico (1997).
To  calculate  the total  losses  resulting  from  environmental  alerts,  the  costs  per day has
been  multiplied by the  number of days  that the contingency  is  expected  to  be in place  for
each of the scenarios described in section 4. Here, the number of days for the first phase con-
tingencies are counted.  The precontingencies  do not have explicit  economic  costs, while the
second phase is never attained.  The costs per year for phase I contingencies  are given in table
6.12 in millions of US$ per year.24
Table 6.12 Industry Losses in Four Scenarios for PM 10 and Ozone  Phase  I Contingencies
(value added per year in millions of US$, 2010 values in  1999 prices)
Scenario  Scenario
Base  Scenario  Scenario  IlI  IV
case  1(10%)  II (20%)  (AQSI)  (AQS2)
Days with PM 1O  contingency  1.0  0.0  0.0  0.0  0.0
Production losses due to PM1 0
Phase  I contingency  4.8  0.0  0.0  0.0  0.0
Days with ozone contingency  10.0  2.0  0.0  0.0  0.0
Production  losses due to
ozone Phase I contingency  45.4  9.1  0.0  0.0  0.0
24 An exchange rate of 4 Pesos to the US$ was taken  for 1995.  These numbers were converted  to 1999 US$.
437. Conclusions and  Recommendations
The health benefits included  in this  study are:25 (i)  reduced  cost  of illness,  (ii) reduced
productivity  losses,  (iii)  willingness  to pay (WTP)  for reduced acute  and chronic  morbidity
effects, measured using  the contingent valuation  method (CVM);  and (iv) WTP  for reduced
mortality effects associated with acute and chronic exposure.  The WTP concept in each case
captures  aspects of the value  of avoiding death and illness  (for example  the pain and suffer-
ing avoided)  above  and beyond  foregone earnings and COI. The largest  single contributor to
the benefit  estimate  is  WTP  for premature  death  due  to  chronic  exposure  to  air pollution.
Given  the  continuing  debate  over the  use  of WTP  for  valuing  health  benefits,  particularly
CVM, we estimate the health benefits both including and excluding this benefit category. The
human capital  and COI can then be interpreted as lower bounds to WTP for reduced mortal-
ity and for reduced morbidity, respectively.
Table 7.1  presents the overall benefit estimates from this study at different income  elas-
ticities used in the benefit transfer of WTP  estimates  from Europe  and the United States to
Mexico.  The central  estimate  of the annual benefits of a  10-percent  reduction  in ozone  and
PMIO  is $759 million (1999 US$).  High and low estimates of the value a  10-percent reduc-
tion are $1,607 million and $154 million, respectively.
Because estimates of the health benefits of reducing each pollutant control for the levels
of other pollutants,  it is appropriate  to add the benefits  of ozone  and PM reduction together
for each  scenario.  This  is done in table  7.2, which  summarizes  the benefits of each  control
scenario, assuming an income elasticity of one in benefits transfer.  The  'high' estimate  given
in Table  7.2 uses benefits of reduced  morbidity in terms of Productivity loss,  cost of illness
and willingness to pay and of reduced mortality in terms of willingness  to pay. The  'central'
estimate  is the same as the 'high'  estimate except that mortality is measured in human capital
losses rather than WTP. The 'low'  estimate deviates from the 'central'  case in that it excludes
WTP estimates for morbidity.
25  In the  literature  on economic  valuation  of morbidity effects  used here,  only  studies  that  specifically
differentiated between the costs categories  (COI, productivity loss, and WTP) were considered.
44Table  7.1  Summary  of Total  Benefits  of a Reduction  in  Air Pollution in Four Scenarios  for
Ozone and  PM10
(in  million US$  per year,  2010 value in  1999 prices, 3 percent discount rate)
Scenario
10%  20%  AQSI  AQS2
Income elasticity  1.0  0.4  1.0  0.4  1.0  0.4  1.0  0.4
Ozone
Health benefit estimate 1 including:
Morbidity (Prod.  loss+  COI  +WTP)
and WTP for mortality  116  183  232  365  717  1129  794  1250
Health  benefit estimate 2 including:
Morbidity (Prod.  loss+  COI +WTP)
and  human capital  losses for mortality  75  114  151  228  465  706  515  782
Health  benefit estimate 3 including:
Morbidity (Prod.  loss + COI)
and human  capital losses for mortality  18  18  35  35  109  109  121  121
Environmental  contingencies benefits  36  36  45  45  45  45  45  45
PM10
Health  estimate 1 including:
Morbidity (Prod.  loss+  COI +WTP)
and WTP for mortality  1451  2549  2903  5098  3186  5595  6793  11931
Health benefit estimate 2 including:
Morbidity (Prod.  loss+ COI +WTP)
and human  capital losses for mortality  644  1184  1289  2367  1414  2598  3016  5540
Health benefit estimate 3 including:
Morbidity (Prod.  loss + COI)
and human  capital losses for mortality  96  96  191  191  210  210  448  448
Environmental contingencies  4  4  4  4  4  4  4  4
Prod. loss = Productivity losses; COI = cost of illness; WTP = willingness to Pay.
Table 7.2 Summary  of Benefits  From  Each  Scenario Using Income  Elasticity of 1.0
(in  million US$  per year, 2010 values in  1999 prices)
Estimates  10%  20%  AQSI  AQS2
High  1607  3184  3952  7636
Central  759  1489  1928  3580
Low  154  275  368  618
The estimates  in  tables 7.1  and 7.2  clearly  show that  the calculated benefits  associated
with air pollution  reduction give an economic basis  for spending to further reduce  polluting
emissions.  Exactly  how  much  is  open  to  debate.  Ideally,  this  study  on  economic  benefits
should be  combined  with  estimates  of emission abatement  costs  to determine  an  economi-
cally justifiable  level  of abatement.  Hence,  conducting  a cost-benefit  analysis  is  the  logical
next  step.  This  would also  necessitate  further advances  in atmospheric  chemistry  modeling
for Mexico  City,  which is needed  to compare  costs  from  emissions reductions with benefits
of lower concentrations  of pollutants.
45The current valuation  study uses meta-analyses  and benefit  transfers.  Additional  epide-
mological  and health-economic  studies in Mexico City would allow estimates of health bene-
fits solidly based on local  data. Also,  the uncertainties  regarding all the estimates presented
above  are  considerable.  Further  research  that  allows  a  reduction  of these  uncertainties  is
highly recommended.
It  should  also  be  noted  that  the  monetary  estimates  of health  benefits  give  a  lower
boundary to actual benefits. For instance,  the human misery associated with a person suffer-
ing from chronic pollution-related  morbidity may be much larger than monetary estimates  in-
dicate.  This is especially the case if this person  is the main wage earner of a poor family who
could slide further into poverty due to a lack of safety net.
As other  studies  have found  (U.S.  EPA  1997,  1999), the health benefits from  reducing
ozone  and PMIo are  dominated by the benefits  of reducing particulate  matter.  In the  case  of
Mexico  City, the benefits  associated with reductions of PM1o are roughly an order of magni-
tude higher than those of ozone. The results must, however,  be interpreted with caution.  Pol-
lution control  strategies that reduce the precursors of ozone, especially NOR, may also reduce
particles.
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